Peptides International, Inc. Datasheets for Organic Chemicals
Organic chemicals are chemical compounds that contain carbon in their molecular structure.
Organic Chemicals: Learn more
| Product Name | Notes |
|---|---|
| (Ammonium Form) Pyr-Gly-Pro-Trp-Leu- Glu-Glu-Glu-Glu-Glu- Ala-Tyr-Gly-Trp-Met- Asp-Phe-NH2 (M.W. 2098.2) C97H124N20O31S [10047-33-3] H. Gregory, P.M. Hardy, D.S. Jones, G.W. Kenner, and R.C. Sheppard, Nature, 204, 931 (1964). (Original) J.C. Anderson, M.A. Barton,... | |
| (Ammonium Form) Pyr-Leu-Gly-Pro-Gln- Gly-Pro-Pro-His-Leu- Val-Ala-Asp-Pro-Ser- Lys-Lys-Gln-Gly-Pro- Trp-Leu-Glu-Glu-Glu- Glu-Glu-Ala-Tyr-Gly- Trp-Met-Asp-Phe-NH2 (M.W. 3849.2) C176H251N43O53S [60675-77-6] A.M. Choudhury, G.W. Kenner, S. Moore, K.L. Ramachandran, W.D. Thorpe, R. Ramage, G.J. Dockray, R.A. Gregory, L. | |
| (Black mamba, Dendroaspis polylepis polylepis) Arg-Ile-Cys-Tyr-Ile- His-Lys-Ala-Ser-Leu- Pro-Arg-Ala-Thr-Lys- Thr-Cys-Val-Glu-Asn- Thr-Cys-Tyr-Lys-Met- Phe-Ile-Arg-Thr-Gln- Arg-Glu-Tyr-Ile-Ser- Glu-Arg-Gly-Cys-Gly- Cys-Pro-Thr-Ala-Met- Trp-Pro-Tyr-Gln-Thr- Glu-Cys-Cys-Lys-Gly- Asp-Arg-Cys-Asn-Lys (Disulfide bonds are between Cys3-Cys22, Cys17-Cys39, Cys41-Cys52, and Cys53-Cys58) (M.W. 7036.1) C299H468N90O87S10 [134710-25-1]... | |
| (Black mamba, Dendroaspis polylepis polylepis) Pyr-Pro-Leu-Arg-Lys- Leu-Cys-Ile-Leu-His- Arg-Asp-Pro-Gly-Arg- Cys-Tyr-Gln-Lys-Ile- Pro-Ala-Phe-Tyr-Tyr- Asn-Gln-Lys-Lys-Lys- Gln-Cys-Glu-Gly-Phe- Thr-Trp-Ser-Gly-Cys- Gly-Gly-Asn-Ser-Asn- Arg-Phe-Lys-Thr-Ile- Glu-Glu-Cys-Arg-Arg- Thr-Cys-Ile-Arg-Lys (Disulfide bonds between Cys7-Cys57, Cys16-Cys40, and Cys32-Cys53) (M.W. 7133.2) C312H487N97O84S6 Voltage-Dependant K+ Channel... | |
| (Canine) Cys-Ser-Cys-Ser-Ser- Trp-Leu-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 2546.9) C115H160N26O32S4 [123562-20-9] A. Inoue, M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto, and T. | |
| (Canine, Rat) Asp-Arg-Val-Tyr-Ile- His-Pro ⢠AcOH ⢠4H2O (M.W. 899.00 ⢠60.05 ⢠72.06) C41H62N12O11 ⢠CH3COOH ⢠4H2O M.T. Schiavone, R.A.S. Santos, K.B. Brosnihan, M.C. Khosla, and C.M. Ferrario,... | |
| (Canine, Rat) Asp-Arg-Val-Tyr-Ile- His-Pro (M.W. 899.00) C41H62N12O11 [51833-78-4] M.T. Schiavone, R.A.S. Santos, K.B. Brosnihan, M.C. Khosla, and C.M. Ferrario, Proc. Natl. Acad. Sci. U.S.A., 85, 4095 (1988). (Original) C.M. Ferrario,... | |
| (Chilean Rose Tarantula, Grammostola spatulata) Gly-Cys-Leu-Glu-Phe- Trp-Trp-Lys-Cys-Asn- Pro-Asn-Asp-Asp-Lys- Cys-Cys-Arg-Pro-Lys- Leu-Lys-Cys-Ser-Lys- Leu-Phe-Lys-Leu-Cys- Asn-Phe-Ser-Phe-NH2 (Disulfide bonds between Cys2-Cys17, Cys9-Cys23, and Cys16-Cys30) (M.W. 4095.8) C185H273N49O45S6 Inhibitor for Cation-Selective Stretch-Activated Channels /Atrial Fibrillation Inhibiting... | |
| (Frog, Bombina bombina) Pyr-Gln-Arg-Leu-Gly- Asn-Gln-Trp-Ala-Val- Gly-His-Leu-Met-NH2 ⢠AcOH ⢠7H2O (M.W. 1619.8 ⢠60.05 ⢠126.11) C71H110N24O18S ⢠CH3COOH ⢠7H2O A. Anastasi, V. Erspamer, and M. Bucci, Experientia, 27,... | |
| (Frog, Bombina bombina) Pyr-Gln-Arg-Leu-Gly- Asn-Gln-Trp-Ala-Val- Gly-His-Leu-Met-NH2 (M.W. 1619.8) C71H110N24O18S [31362-50-2] A. Anastasi, V. Erspamer, and M. Bucci, Experientia, 27, 166 (1971). (Original) V. Erspamer and P. Melchiorri, Trends Pharmacol. Sci.,... | |
| (Frog, Xenopus laevis) Gly-Ile-Gly-Lys-Phe- Leu-His-Ser-Ala-Gly- Lys-Phe-Gly-Lys-Ala- Phe-Val-Gly-Glu-Ile- Met-Lys-Ser (M.W. 2409.8) C112H177N29O28S [108433-99-4] Potent Antimicrobial Peptide M. Zasloff, Proc. Natl. Acad. Sci. USA, 84, 5449 (1987). (Original) | |
| (Fungus, Pseudoplectania nigrella) Gly-Phe-Gly-Cys-Asn- Gly-Pro-Trp-Asp-Glu- Asp-Asp-Met-Gln-Cys- His-Asn-His-Cys-Lys- Ser-Ile-Lys-Gly-Tyr- Lys-Gly-Gly-Tyr-Cys- Ala-Lys-Gly-Gly-Phe- Val-Cys-Lys-Cys-Tyr (M.W. 4401.9) C189H267N53O56S7 Antimicrobial Peptide Mygind, et al., Nature, 437, 975 (2005). (Original ; Structure & Antimicrobial Activity) | |
| (Green Mamba, Dendroaspis angusticeps) Trp-Gln-Pro-Pro-Trp- Tyr-Cys-Lys-Glu-Pro- Val-Arg-Ile-Gly-Ser- Cys-Lys-Lys-Gln-Phe- Ser-Ser-Phe-Tyr-Phe- Lys-Trp-Thr-Ala-Lys- Lys-Cys-Leu-Pro-Phe- Leu-Phe-Ser-Gly-Cys- Gly-Gly-Asn-Ala-Asn- Arg-Phe-Gln-Thr-Ile- Gly-Glu-Cys-Arg-Lys- Lys-Cys-Leu-Gly-Lys (Disulfide bonds between Cys7-Cys57, Cys16-Cys40, and Cys32-Cys53) (M.W. 6980.1) C321H476N86O78S6 Neuronal L-type Ca2+ Channel... | |
| (Honeybee, Apis mellifera) Cys-Asn-Cys-Lys-Ala- Pro-Glu-Thr-Ala-Leu- Cys-Ala-Arg-Arg-Cys- Gln-Gln-His-NH2 (Disulfide bond between Cys1-Cys11 and Cys3-Cys15) (M.W. 2027.3) C79H131N31O24S4 [24345-16-2] Small Conductance Ca2+-Activated K+ Channel Blocker E. Haberman, Pharmacol. Ther., 25, 255 (1984). | |
| (Human, Bovine, Rat, Mouse) Arg-Pro-Pro-Gly-Phe- Ser-Pro-Phe-Arg ⢠2AcOH ⢠3H2O (M.W. 1060.2 ⢠120.10 ⢠54.05) C50H73N15O11 ⢠2CH3COOH ⢠3H2O D.F. Elliott, G.P. Lewis, and E.W. Horton, Biochem. J.,... | |
| (Human, Bovine, Rat, Mouse) Arg-Pro-Pro-Gly-Phe- Ser-Pro-Phe-Arg (M.W. 1060.2) C50H73N15O11 [58-82-2] D.F. Elliott, G.P. Lewis, and E.W. Horton, Biochem. J., 76, 16P (1960). (Original; Bovine) E.D. Nicolaides and H.A. DeWald, J. | |
| (Human, Porcine, Bovine, Rat, Mouse) Tyr-Gly-Gly-Phe-Leu ⢠H2O (M.W. 555.62 ⢠18.02) C28H37N5O7 ⢠H2O [58822-25-6] J. Hughes, T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan, and H.R. Morris, Nature,... | |
| (Human, Porcine, Bovine, Rat, Mouse) Tyr-Gly-Gly-Phe-Leu (M.W. 555.62) C28H37N5O7 [58822-25-6] J. Hughes, T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan, and H.R. Morris, Nature, 258, 577 (1975). (Original; Porcine) M. | |
| (Human, Porcine, Bovine, Rat, Mouse) Tyr-Gly-Gly-Phe-Met ⢠H2O (M.W. 573.66 ⢠18.02) C27H35N5O7S ⢠H2O [58569-55-4] J. Hughes, T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan, and H.R. Morris, Nature,... | |
| (Human, Porcine, Bovine, Rat, Mouse) Tyr-Gly-Gly-Phe-Met (M.W. 573.66) C27H35N5O7S [58569-55-4] J. Hughes, T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan, and H.R. Morris, Nature, 258, 577 (1975). (Original; Porcine) M. | |
| (Hydrochloride Form) Glu-Glu-Glu-Glu-Glu- Met-Ala-Val-Val-Pro- Gln-Gly-Leu-Phe-Arg- Gly-NH2 (M.W. 1819.0) C78H123N21O27S D.S. Konecki, U.M. Benedum, H.H. Gerdes, and W.B. Huttner, J. Biol. Chem., 262, 17026 (1987). (Original; cDNA) | |
| (Hydrochloride Form) Trp-Met-Asp-Phe-NH2 (M.W. 596.70) C29H36N6O6S J.F. Rehfeld, L.l. Larsson, N.R. Goltermann, T.W. Schwartz, J.J. Holst, S.L. Jensen, and J.S. Morley, Nature, 284, 33 (1980). (Neural Pharmacol.) J.E. Jorpes and... | |
| (Leech, Macrobdella decora) Ala-Pro-Arg-Leu-Pro- Gln-Cys-Gln-Gly-Asp- Asp-Gln-Glu-Lys-Cys- Leu-Cys-Asn-Lys-Asp- Glu-Cys-Pro-Pro-Gly- Gln-Cys-Arg-Phe-Pro- Arg-Gly-Asp-Ala-Asp- Pro-Tyr-Cys-Glu (Disulfide bonds are formed between Cys7-Cys15, Cys17-Cys27, and Cys22-Cys38) (M.W. 4377.8) C179H271N55O62S6 Glycoprotein IIb / IIIa Antagonist, Platelet Aggregation... | |
| (Lizard, Heloderma horridum) Thr-Phe-Thr-Ser-Asp- Leu-Ser-Lys-Gln-Met- Glu-Glu-Glu-Ala-Val- Arg-Leu-Phe-Ile-Glu- Trp-Leu-Lys-Asn-Gly- Gly-Pro-Ser-Ser-Gly- Ala-Pro-Pro-Pro-Ser- NH2 (M.W. 3806.2) C169H262N44O54S GLP-1 Receptor Antagonist C. Montrose-Rafizadeh, H. Yang, B.D. Rodgers, A. Beday, L.A. Pritchette, and J. Eng,... | |
| (M.W. 1274.4 ⢠72.06) C60H87N15O16 ⢠4H2O Purity: higher than 97% by HPLC K. Kivirrikko, K. Suga, Y. Kishida, S. Sakakibara, and D.J. Prockop, Biochem. Biophys. Res. Commun., 45, 1591... | |
| (M.W. 1319.6 ⢠180.16 ⢠36.03) C61H94N18O13S ⢠3CH3COOH ⢠2H2O D.F. Elliott and G.P. Lewis, Biochem. J., 95, 437 (1965). (Original; Bovine) I. Ohkubo, K. Kurachi, T. Takasawa, H. | |
| (M.W. 1354.4 ⢠180.15) C60H87N15O21 ⢠10H2O Purity: higher than 96% by HPLC S. Sakakibara, K. Inouye, K. Shudo, Y. Kishida, Y. Kobayashi, and D.J. Prockop, Biochim. Biophys. Acta., 303,... | |
| (M.W. 2530.8 ⢠162.14) C120H172N30O31 ⢠9H2O Purity: higher than 95% by HPLC S. Sakakibara, Y. Kishida, Y. Kikuchi, R. Sakai, and K. Kakiuchi, Bull. Chem. Soc. Japan, 41, 1273... | |
| (M.W. 2690.8 ⢠360.30) C120H172N30O41 ⢠20H2O Purity: higher than 90% by HPLC S. Sakakibara, K. Inouye, K. Shudo, Y. Kishida, Y. Kobayashi, and D.J. Prockop, Biochim. Biophys. Acta., 303,... | |
| (M.W. 304.26 ⢠18.02) C11H16N2O8 ⢠H2O [3106-85-2] Endogenous Excitatory Neurotransmitter K.L. Reichert and F. Fonnum, J. Neurochem., 16, 1409 (1969). (Original) K.J. Koller and J.T. Coyle, Eur. J. Pharm.,... | |
| (M.W. 490.47 ) C17H30N8O9 S.K. Akiyama and K.M. Yamada, J. Biol. Chem., 260, 10402 (1985). (Original) K. Olden, S. Mohla, S.A. Newton, S.L. White, and M.J. Humphries, Ann. N. Y. | |
| (M.W. 575.63) C22H41N9O9 Negative Control for PLI-3929-PI | |
| (M.W. 643.82 ⢠120.11 ⢠36.03) C32H53N9O5 ⢠2CH3COOH ⢠2H2O Chicken Brain Peptide G.J. Dockray, J.R. Reeve Jr., J. Shively, R.J. Gayton, and C.S. Barnard, Nature, 305, 328 (1983). | |
| (M.W. 656.83) C29H56N10O7 Protease-Activated Receptor 2 (PAR2) Negative Control for PAR-3664-PI H. Nishikawa, K. Kawai, M. Tanaka, H. Ohtani, S. Tanaka, C. Kitagawa, M. Nishida, T. Abe, H. Araki, and... | |
| (Marine Snail, Conus geographus) (Hydrochloride Form) Glu-Cys-Cys-Asn-Pro- Ala-Cys-Gly-Arg-His- Tyr-Ser-Cys-NH2 (Disulfide bonds between Cys2-Cys7 and Cys3-Cys13) (M.W. 1437.6) C55H80N20O18S4 [76862-65-2] Blocker for Nicotinic Acetylcholine Receptor W.R. Gray, A. Luque, B.M. Olivera,... | |
| (Marine snail, Conus geographus) Ala-Cys-Ser-Gly-Arg- Gly-Ser-Arg-Cys-Hyp- Hyp-Gln-Cys-Cys-Met- Gly-Leu-Arg-Cys-Gly- Arg-Gly-Asn-Pro-Gln- Lys-Cys-Ile-Gly-Ala- His-Gla-Asp-Val (Gla: L-gamma-Carboxygluta mic acid) (Disulfide bonds between Cys2-Cys14, Cys9-Cy | |
| (Marine Snail, Conus geographus) Arg-Asp-Cys-Cys-Thr- Hyp-Hyp-Arg-Lys-Cys- Lys-Asp-Arg-Arg-Cys- Lys-Hyp-Met-Lys-Cys- Cys-Ala-NH2 (Disulfide bonds between Cys3-Cys15, Cys4-Cys20, and Cys10-Cys21) (M.W. 2640.2) C101H175N39O30S7 Na+ Channel Blocker: Specifi | |
| (Marine Snail, Conus geographus) Cys-Lys-Ser-Hyp-Gly- Ser-Ser-Cys-Ser-Hyp- Thr-Ser-Tyr-Asn-Cys- Cys-Arg-Ser-Cys-Asn- Hyp-Tyr-Thr-Lys-Arg- Cys-Tyr-NH2 (Disulfide bonds between Cys1-Cys16, Cys8-Cys19, and Cys15-Cys26) (M.W. 3037.3) C120H182N38O43S6 [106375 | |
| (Marine Snail, Conus geographus) Gly-Glu-Gla-Gla-Leu- Gln-Gla-Asn-Gln-Gla- Leu-Ile-Arg-Gla-Lys- Ser-Asn-NH2 (Gla: L-gamma-Carboxygluta mic acid) (M.W. 2264.2) C88H138N26O44 [93438-65-4] Sleeper Peptide, N-Methyl-D-Aspartate (NMDA) Receptor Antagonist J.M. McIntosh, B.M. Olivera, L.J. Cruz, and W.R. | |
| (Marine Snail, Conus imperialis) Gly-Cys-Cys-Ser-Asp- Pro-Arg-Cys-Ala-Trp- Arg-Cys-NH2 (Disulfide bonds between Cys2-Cys8 and Cys3-Cys12) (M.W. 1351.6) C52H78N20O15S4 [156467-85-5] Blocker for Nicotinic Acetylcholine Receptor in Central Nervous System | |
| (Marine Snail, Conus magus) Cys-Lys-Gly-Lys-Gly- Ala-Lys-Cys-Ser-Arg- Leu-Met-Tyr-Asp-Cys- Cys-Thr- Gly-Ser-Cys-Arg-Ser- Gly-Lys-Cys-NH2 (Disulfide bonds between Cys1-Cys16,Cys8-Cys2 0,and Cys15-Cys25) (M.W. 2639.1) C102H172N36O32S7 [107452-89-1] Reversi | |
| (Marine Snail, Conus magus) Cys-Lys-Gly-Lys-Gly- Ala-Pro-Cys-Arg-Lys- Thr-Met-Tyr-Asp-Cys- Cys-Ser-Gly-Ser-Cys- Gly-Arg-Arg-Gly-Lys- Cys-NH2 (Disulfide bonds between Cys1-Cys16,Cys8-Cys2 0, and Cys15-Cys26) (M.W. 2749.3) C106H178N40O32S7 [147794-23-8] | |
| (Marine Snail, Conus magus) Gly-Arg-Cys-Cys-His- Pro-Ala-Cys-Gly-Lys- Asn-Tyr-Ser-Cys-NH2 (Disulfide bonds between Cys3-Cys8 and Cys4-Cys14) (M.W. 1493.7) C58H88N22O17S4 Blocker for Nicotinic Acetylcholine Receptor M. McIntosh, L.J. Cruz, M.W. Hunkapiller, W.R. Gray, and... | |
| (Marine Snail, Conus striatus) Cys-Lys-Leu-Lys-Gly- Gln-Ser-Cys-Arg-Lys- Thr-Ser-Tyr-Asp-Cys- Cys-Ser-Gly-Ser-Cys- Gly-Arg-Ser-Gly-Lys- Cys-NH2 (Disulfide bonds between Cys1-Cys16,Cys8-Cys2 0, and Cys15-Cys26) (M.W. 2739.1) C105H176N38O36S6 [150433-82-2] | |
| (Marine Snail, Conus striatus) Ile-Cys-Cys-Asn-Pro- Ala-Cys-Gly-Pro-Lys- Tyr-Ser-Cys-NH2 (Disulfide bonds between Cys2-Cys7 and Cys3-Cys7) (M.W. 1353.6) C55H84N16O16S4 Blocker for Nicotinic Acetylcholine Receptor G.C. Zafaralla, C. Ramilo, W.R. Gray, | |
| (Marine Snail, Conus tulipa) Gly-Glu-Gla-Gla-Tyr- Gln-Lys-Met-Leu-Gla- Asn-Leu-Arg-Gla-Ala- Glu-Val-Lys-Lys-Asn- Ala-NH2 (Gla: L-gamma-Carboxygluta mic acid) (M.W. 2683.8) C110H175N31O45S Sleeper Peptide, N-Methyl-D-Aspartate (NMDA) Receptor Antagonist J.A. Haack, J. Rivier, T.N. Parks, E.E. Mena,... | |
| (MIF) Pro-Leu-Gly-NH2 ⢠½H2O (M.W. 284.35 ⢠9.01) C13H24N4O3 ⢠½ H2O [2002-44-0] A. Vivas and M.E. Celis, J. Endocrinol., 78, 1 (1978). (Pharmacol.) | |
| (Porcine, Canine, Rat, Mouse, Bovine) Cys-Ser-Cys-Ser-Ser- Leu-Met-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 2491.9) C109H159N25O32S5 [117399-94-7] M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi,... | |
| (Porcine, Canine, Rat, Rabbit, Guinea pig) Asp-Arg-Val-Tyr-Ile- His-Pro-Phe-His-Leu ⢠2AcOH ⢠4H2O (M.W. 1296.5 ⢠120.10 ⢠72.06) C62H89N17O14 ⢠2CH3COOH ⢠4H2O [70937-97-2] K. Arakawa, M. Nakatani, A. Minohara,... | |
| (Porcine, Canine, Rat, Rabbit, Guinea pig) Asp-Arg-Val-Tyr-Ile- His-Pro-Phe-His-Leu (M.W. 1296.5) C62H89N17O14 [484-42-4] K. Arakawa, M. Nakatani, A. Minohara, and M. Nakamura, Biochem. J., 104, 900 (1967). (Original; Human) H. Akagi,... | |
| (Porcine, Rat) Luteinizing Hormone Releasing Hormone (Human) (GnRH: Gonadotropin-Releasi ng Hormone) (Porcine, Rat) Pyr-His-Trp-Ser-Tyr- Gly-Leu-Arg-Pro-Gly- NH2 ⢠2AcOH ⢠4H2O (M.W. 1182.3 ⢠120.10 ⢠72.06) C55H75N17O13 ⢠2CH3COOH ⢠| |
| (Porcine, Rat) Luteinizing Hormone Releasing Hormone (Human) (GnRH: Gonadotropin-Releasi ng Hormone) (Porcine, Rat) Pyr-His-Trp-Ser-Tyr- Gly-Leu-Arg-Pro-Gly- NH2 (M.W. 1182.3) C55H75N17O13 [33515-09-2] H. Matsuo, Y. Baba, R.M.G. Nair, A. Arimura, and A.V. | |
| (Porcine, Rat, Bovine) Tyr-Gly-Gly-Phe-Leu- Arg-Arg-Ile-Arg-Pro- Lys-Leu-Lys ⢠5AcOH ⢠6H2O (M.W. 1604.0 ⢠300.26 ⢠108.09) C75H126N24O15 ⢠5CH3COOH ⢠6H2O A. Goldstein, S. Tachibana, L.I. Lowney, M. Hunkapiller, and... | |
| (Porcine, Rat, Bovine) Tyr-Gly-Gly-Phe-Leu- Arg-Arg-Ile-Arg-Pro- Lys-Leu-Lys (M.W. 1604.0) C75H126N24O15 [72957-38-1] A. Goldstein, S. Tachibana, L.I. Lowney, M. Hunkapiller, and L. Hood, Proc. Natl. Acad. Sci. U.S.A., 76, 6666 (1979). (Original; | |
| (Porcine, Rat, Bovine) Tyr-Gly-Gly-Phe-Leu- Arg-Arg-Ile-Arg-Pro- Lys-Leu-Lys-Trp-Asp- Asn-Gln (M.W. 2147.5) C99H155N31O23 [80448-90-4] S. Tachibana, K. Araki, S. Ohya, and S. Yoshida, The 1981 International Narcotic Research Conference, Kyoto, July 1981. (Original)... | |
| (Porcine, Rat, Rabbit) Cys-Thr-Cys-Phe-Thr- Tyr-Lys-Asp-Lys-Glu- Cys-Val-Tyr-Tyr-Cys- His-Leu-Asp-Ile-Ile- Trp (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 2643.0) C121H168N26O33S4 [117399-93-6] M. Yanagisawa, A. Inoue, T. Ishikawa, Y. Kasuya, S. Kimura, S. Kumagaye,... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: [Pyr33]-Pancreastati n (Porcine, 33-49)-TG (TG: Bovine Thyroglobulin) Specificity: [Pyr33]-Pancreastati n (Porcine, 33-49) 100% Pancreastatin (Porcine, 1-49) 100% Chromogranin A... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: beta-Defensin-2 (Human)-TG (TG: Bovine Thyroglobulin) Reactivity: beta-Defensin-2 (Human) + beta-Defensin-1 (Human) - alpha-Defensin-1 (Human) - Our undiluted antisera are... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Big Endothelin-1 (Human, 22-38)-BSA (BSA: Bovine Serum Albumin) Specificity: Big Endothelin-1 (Human, 1-38) 100% Big Endothelin-1 (Human, 22-38) 50%... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Big Endothelin-1 (Porcine, 22-39)-BSA (BSA: Bovine Serum Albumin) Specificity: Big Endothelin-1 (Porcine, 22-39) 100% Big Endothelin-1 (Porcine, 1-39) 100%... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Big Endothelin-2 (Human, 22-37)-BSA (BSA: Bovine Serum Albumin) Specificity: Big Endothelin-2 (Human, 1-37) 100% Big Endothelin-2 (Human, 1-38) 0%... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Big Endothelin-2 (Human, 22-38)-BSA (BSA: Bovine Serum Albumin) Specificity: Big Endothelin-2 (Human, 1-38) 100% Big Endothelin-2 (Human, 22-38) 200%... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Big Endothelin-3 (Human, 22-41 Amide)-BSA (BSA: Bovine Serum Albumin) Specificity: Big Endothelin-3 (Human, 1-41 Amide) 100% Big Endothelin-3 (Human,... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Calcitonin (Human)-TG (TG: Bovine Thyroglobulin) Specificity: Calcitonin (Human) 100% Calcitonin (Human, 11-32) 100% Calcitonin (Rat) 100% Calcitonin (Salmon) 0%... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: CCK-33 (Porcine)-TG (TG: Bovine Thyroglobulin) Specificity: CCK-33 (Porcine, Sulfated) 100% CCK-33 (Human, Sulfated) 60% Gastrin l <0.1% CCK-8 (Sulfated... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Elafin (Human, 1-57) (Carrier-free) Specificity: Elafin (Human) 100% Cross-reactions were not observed at higher doses (1-10 nmol/ml) against the... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Endothelin-1 (Human, 1-21)-TG (TG: Bovine Thyroglobulin) Specificity: Endothelin 1 (Human) 100% Endothelin-2 (Human) 60% Endothelin 3 (Human) 40% Big... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Galanin (Rat)-BSA (BSA: Bovine Serum Albumin) Specificity: Galanin (Rat) 100% Galanin (Rat, 1-16) 0% Galanin (Human) 0% Cross-reactions were... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Lysenin (Carrier-free) Reactivity: Lysenin + For Immunohistochemistry : x 100 - 1,000 dilution Our undiluted antisera are suitable for... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Midkine (Human, 1-59)-TG (TG: Bovine Thyroglobulin) Reactivity: Midkine (Human) + Midkine (Human, 1-59) + Midkine (Human, 60-121) - Pleiotrophin... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Orexin-A (Human)-BSA (BSA: Bovine Serum Albumin) Reactivity: Orexin-A (Human) + Orexin-B (Human) + Orexin-B (Rat) + GLP-1 (7-36 Amide)... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Osteocalcin (Human, 38-49)-BSA (BSA: Bovine Serum Albumin) Specificity: Gla17,21,24-Osteocal cin (Human, 1-49) 100% Glu17,Gla21,24-Osteo calcin (Human, 1-49) 100% Osteocalcin... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Secretin (Porcine)-TG (TG: Bovine Thyroglobulin) Specificity: Secretin (Porcine) 100% Secretin (Human) 100% Secretin (Chicken) 0% Cross-reactions were not observed... | |
| (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Urotensin II (Human)-BSA (BSA: Bovine Serum Albumin) Reactivity: Urotensin II (Human) ++ Urotensin II (Rat) + Endothelin-1 - Somatostatin... | |
| (Rabbit, Mouse) A-Type (Atrial) Natriuretic Peptide (Rat, 1-28) Ser-Leu-Arg-Arg-Ser- Ser-Cys-Phe-Gly-Gly- Arg-Ile-Asp-Arg-Ile- Gly-Ala-Gln-Ser-Gly- Leu-Gly-Cys-Asn-Ser- Phe-Arg-Tyr (Disulfide bond between Cys7-Cys23) (M.W. 3062.4) C128H205N45O39S2 [88898-17-3] T.G. Flynn, M.L. DeBold, and A.J. DeBold, Biochem. | |
| (Rabbit, Mouse) A-Type (Atrial) Natriuretic Peptide (Rat, 1-28) T.G. Flynn, M.L. DeBold, and A.J. DeBold, Biochem. Biophys. Res. Commun., 117, 859 (1983). (Original) T.X. Watanabe, Y. Noda, N. Chino, Y. | |
| (Scorpion, Androctonus mauretanicus mauretanicus) Gly-Val-Glu-Ile-Asn- Val-Lys-Cys-Ser-Gly- Ser-Pro-Gln-Cys-Leu- Lys-Pro-Cys-Lys-Asp- Ala-Gly-Met-Arg-Phe- Gly-Lys-Cys-Met-Asn- Arg-Lys-Cys-His-Cys- Thr-Pro (Disulfide bonds between Cys8-Cys28, Cys14-Cys33, and Cys18-Cys35) (M.W. 4021.8) C165H271N53O48S8 High Conductance Ca2+-Activated K+ Channel Blocker M. Crest,... | |
| (Scorpion, Centruroides margaritatus) Thr-Ile-Ile-Asn-Val- Lys-Cys-Thr-Ser-Pro- Lys-Gln-Cys-Leu-Pro- Pro-Cys-Lys-Ala-Gln- Phe-Gly-Gln-Ser-Ala- Gly-Ala-Lys-Cys-Met- Asn-Gly-Lys-Cys-Lys- Cys-Tyr-Pro-His (Disulfide bonds between Cys7-Cys29,Cys13-Cys 34, and Cys17-Cys36) (M.W. 4178.9) C178H286N52O50S7 [145808-47-5] Volgate-Dependent K+ Channel Blocker (Specific for Kv1.3 Channel)... | |
| (Scorpion, Leiurus quinquestriatus hebraeus) Pyr-Phe-Thr-Asn-Val- Ser-Cys-Thr-Thr-Ser- Lys-Glu-Cys-Trp-Ser- Val-Cys-Gln-Arg-Leu- His-Asn-Thr-Ser-Arg- Gly-Lys-Cys-Met-Asn- Lys-Lys-Cys-Arg-Cys- Tyr-Ser (Disulfide bonds between Cys7-Cys28, Cys13-Cys33, and Cys17-Cys35) (M.W. 4295.9) C176H277N57O55S7 Ca2+-Activated K+ Channel Blocker M.L. Garcia, H.-G. Knaus,... | |
| (Scorpion, Leiurus quinquestriatus) Met-Cys-Met-Pro-Cys- Phe-Thr-Thr-Asp-His- Gln-Met-Ala-Arg-Lys- Cys-Asp-Asp-Cys-Cys- Gly-Gly-Lys-Gly-Arg- Gly-Lys-Cys-Tyr-Gly- Pro-Gln-Cys-Leu-Cys- Arg-NH2 (Disulfide bonds between Cys2-Cys19,Cys5-Cys2 8,Cys16-Cys33 and Cys20-Cys35) (M.W. 3995.7) C158H249N53O47S11 Small-Conductance Cl- Channel Blocker J.A. DeBin, J.E. Maggio, and... | |
| (Scorpion, Parabuthus transvaalicus) Lys-Ile-Asp-Gly-Tyr- Pro-Val-Asp-Tyr-Trp- Asn-Cys-Lys-Arg-Ile- Cys-Trp-Tyr-Asn-Asn- Lys-Tyr-Cys-Asn-Asp- Leu-Cys-Lys-Gly-Leu- Lys-Ala-Asp-Ser-Gly- Tyr-Cys-Trp-Gly-Trp- Thr-Leu-Ser-Cys-Tyr- Cys-Gln-Gly-Leu-Pro- Asp-Asn-Ala-Arg-Ile- Lys-Arg-Ser-Gly-Arg- Cys-Arg-Ala (Disulfide bonds between Cys12-Cys61Cys16-Cys 37, Cys23-Cys44, and Cys27-Cys46) (M.W. 7386.4) C324H478N94O90S8 T-type Ca2+ Channel... | |
| (Spider, Agelena opulenta) Gly-Gly-Cys-Leu-Pro- His-Asn-Arg-Phe-Cys- Asn-Ala-Leu-Ser-Gly- Pro-Arg-Cys-Cys- Ser-Gly-Leu-Lys-Cys- Lys-Glu-Leu-Ser-Ile- Trp-Asp-Ser-Arg-Cys- Leu-NH2 (Disulfide bonds between Cys3-Cys19, Cys10-Cys24 and Cys18-Cys34) (M.W. 3818.5) C160H254N52O45S6 Presynaptic Ca2+ Channel Antagonist K. Hagiwara, T. Sakai, A. | |
| (Tarantula, Hysterocrates gigas) Gly-Val-Asp-Lys-Ala- Gly-Cys-Arg-Tyr-Met- Phe-Gly-Gly-Cys-Ser- Val-Asn-Asp-Asp-Cys- Cys-Pro-Arg-Leu-Gly- Cys-His-Ser-Leu-Phe- Ser-Tyr-Cys-Ala-Trp- Asp-Leu-Thr-Phe-Ser- Asp (Disulfide bonds between Cys7-Cys21, Cys14-Cys26, and Cys20-Cys33) (M.W. 4495.0 ) C192H274N52O60S7 Synthetic Product Class-E (R-Type) Ca2+ Channel Blocker... | |
| (Trifluoroacetate Form) Asp-Ala-Glu-Phe-Arg- His-Asp-Ser-Gly-Tyr- Glu-Val-His-His-Gln- Lys-Leu-Val-Phe-Phe- Ala-Glu-Asp-Val-Gly- Ser-Asn-Lys-Gly-Ala- Ile-Ile-Gly-Leu-Met- Val-Gly-Gly-Val-Val (M.W. 4329.8) C194H295N53O58S [131438-79-4] Peptide Deposited in the Brain of Alzheimer's Disease Patient B.A. Yankner, L.K. Duffy, and D.A. Kirschner,... | |
| (Trifluoroacetate Form) Asp-Ala-Glu-Phe-Arg- His-Asp-Ser-Gly-Tyr- Glu-Val-His-His-Gln- Lys-Leu-Val-Phe-Phe- Ala-Glu-Asp-Val-Gly- Ser-Asn-Lys-Gly-Ala- Ile-Ile-Gly-Leu-Met- Val-Gly-Gly-Val-Val- Ile-Ala (M.W. 4514.0) C203H311N55O60S [107761-42-2] Major Plaque Component in Alzheimerâs Disease D. Goldgaber, M.I. Lerman, O.W. McBride, U. Saffiotti, and... | |
| (Trifluoroacetate Form) Asp-Ala-Glu-Phe-Arg- His-Asp-Ser-Gly-Tyr- Glu-Val-His-His-Gln- Lys-Leu-Val-Phe-Phe- Ala-Glu-Asp-Val-Gly- Ser-Asn-Lys-Gly-Ala- Ile-Ile-Gly-Leu-Met- Val-Gly-Gly-Val-Val- Ile-Ala-Thr (M.W. 4615.1) C207H318N56O62S [134500-80-4] Major Plaque Component in Alzheimerâs Disease A. Tamaoka, T. Kondo, A. Odaka, N. Sahara, N. | |
| (Trifluoroacetate Form) Gly-Ser-Asn-Lys-Gly- Ala-Ile-Ile-Gly-Leu- Met (M.W. 1060.3) C45H81N13O14S [131602-53-4] Neurotrophic / Neurodegenerative Peptide B.A. Yankner, L.K. Duffy, and D.A. Kirschner, Science, 250, 279 (1990). (Original) L. Meda, M.A. Cassatella, G.I. | |
| (Trifluoroacetate Form) Gly-Ser-Ser(n-Octano yl)-Phe-Leu-Ser-Pro- Glu-His-Gln-Arg-Val- Gln-Gln-Arg-Lys-Glu- Ser-Lys-Lys-Pro-Pro- Ala-Lys-Leu-Gln-Pro- Arg (M.W. 3370.9) C149H249N47O42 [258279-04-8] Endogenous Growth-Hormone Releasing Peptide with Novel Regulatory Mechanism M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. | |
| (Trifluoroacetate Form) Gly-Ser-Ser(n-Octano yl)-Phe-Leu-Ser-Pro- Glu-His-Gln-Lys-Ala- Gln-Gln-Arg-Lys-Glu- Ser-Lys-Lys-Pro-Pro- Ala-Lys-Leu-Gln-Pro- Arg (M.W. 3314.8) C147H245N45O42 [258338-12-4] Endogenous Growth-Hormone Releasing Peptide with Novel Regulatory Mechanism M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. | |
| (Trifluoroacetate Form) Met-Ala-Pro-Arg-Gly- Phe-Ser-Cys-Leu-Leu- Leu-Leu-Thr-Gly-Glu- Ile-Asp-Leu-Pro-Val- Lys-Arg-Arg-Ala (M.W. 2657.2) C118H202N34O31S2 [330936-70-4] Potent Rescue Factor Abolishing Neuronal Cell Death Y. Hashimoto, T. Niikura, H. Tajima, T. Yasukawa, H. Sudo, Y. Ito,... | |
| (Trifluoroacetate Form) Met-Ala-Pro-Arg-Gly- Phe-Ser-Cys-Leu-Leu- Leu-Leu-Thr-Ser-Glu- Ile-Asp-Leu-Pro-Val- Lys-Arg-Arg-Ala (M.W. 2687.2) C119H204N34O32S2 [330936-69-1] Endogenous Rescue Factor Abolishing Neuronal Cell Death Y. Hashimoto, T. Niikura, H. Tajima, T. Yasukawa, H. Sudo, Y. Ito,... | |
| (Trifluoroacetate Form) Pyr-Phe-Arg-His-Asp- Ser-Gly-Tyr-Glu-Val- His-His-Gln-Lys-Leu- Val-Phe-Phe-Ala-Glu- Asp-Val-Gly-Ser-Asn- Lys-Gly-Ala-Ile-Ile- Gly-Leu-Met-Val-Gly- Gly-Val-Val-Ile-Ala (M.W. 4309.9) C196H299N53O55S [183449-57-2] Major Neuritic Plaque Component in Alzheimerâs Disease T.C. Saido, T. Iwatsubo, D.M.A. Mann, H. Shimada, Y. | |
| (Wasp, Vespula lewisii) Ile-Asn-Leu-Lys-Ala- Leu-Ala-Ala-Leu-Ala- Lys-Lys-Ile-Leu-NH2 ⢠4AcOH ⢠6H2O (M.W. 1478.9 ⢠240.21 ⢠108.09) C70H131N19O15 ⢠4CH3COOH ⢠6H2O Y. Hirai, T. Yasuhara, H. Yoshida, T. Nakajima, M. | |
| (Wasp, Vespula lewisii) Ile-Asn-Leu-Lys-Ala- Leu-Ala-Ala-Leu-Ala- Lys-Lys-Ile-Leu-NH2 (M.W. 1478.9) C70H131N19O15 [72093-21-1] Y. Hirai, T. Yasuhara, H. Yoshida, T. Nakajima, M. Fujino, and C. Kitada, Chem. Pharm. Bull., 27, 1942 (1979). (Original; | |
| (Yeast, Saccharomyces cerevisiae) Trp-His-Trp-Leu-Gln- Leu-Lys-Pro-Gly-Gln- Pro-Met-Tyr (M.W. 1684.0) C82H114N20O17S [59401-28-4] D. Stöetzler, H.-H. Kilts, and W. Duntze, Eur. J. Biochem., 69, 397 (1976). (Original) T. Tanaka, H. Kita, T. Murakami,... | |
| 2-Furoyl-Leu-Ile-Gly -Arg-Leu-Orn-NH2 2-Furoyl-LIGRLO-Amid e (M.W. 777.97) C36H63N11O8 Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist J.J. McGuire, M. Saifeddine, C.R. Triggle, K. Sun, and M.D. Hollenberg, J Pharmacol. Exp. Ther.,... | |
| 2-Furoyl-OLRGIL-Amid e Protease-Activated Receptor 2 (PAR2 ) Negative Control Peptide for PAR-3663-PI J.J. McGuire, M. Saifeddine, C.R. Triggle, K. Sun, and M.D. Hollenberg, J. of Pharm. Exp. Ther., 309, 1124... | |
| 3-Mercaptopropionyl- F-Cha-Cha-RKNDK-Amid e (M.W. 1297.61) C61H100N16O13S Protease-Activated Receptor 1 (PAR1) Antagonist / Protease-Activated Receptor 2 (PAR2) Agonist A. Kawabata, M. Saifeddine, B. Al-Ani, L. Leblond and M.D. Hollenberg, J. Pharmacol. | |
| [Carnosine] (M.W. 226.23) C9H14NO2 [305-84-0] Grade AA | |
| [D-Lys3]-Growth Hormone Releasing Peptide-6 (GHRP-6) (M.W. 930.13) C49H63N13O6 Ghrelin Antagonist K. Fujino, A. Inui, A. Asakawa, N. Kihara, M. Fujimura, and M. Fujimiya, J. Physiol., 550, 227 (2003). | |
| [Glutathione; GSH] gamma-L-Glutamyl-L-C ysteinyl-Glycine (M.W. 307.32) C10H17N3O6S [70-18-8] Grade B | |
| [His1,Lys6]-Growth Hormone Releasing Peptide (GHRP-6) (M.W. 873.04) C46H56N12O6 C.Y. Bowers, F.A. Monamy, G.A. Renolds, and A. Hong, Endocrinol., 114, 1537 (1984). | |
| [Met(O)12]-A-Type (Atrial) Natriuretic Peptide (Human, 1-28) Ser-Leu-Arg-Arg-Ser- Ser-Cys-Phe-Gly-Gly- Arg-Met(O)-Asp-Arg-I le-Gly-Ala-Gln-Ser-G ly-Leu-Gly-Cys-Asn-S er-Phe-Arg-Tyr (Disulfide bond between Cys7-Cys23) (M.W. 3096.4) C127H203N45O40S3 T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. | |
| A-Type (Atrial) Natriuretic Peptide (Human, 1-28) (Porcine, Bovine, Canine) K. Kangawa and H. Matsuo, Biochem. Biophys. Res. Commun., 118, 131 (1984). (Original) T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi,... | |
| A-Type (Atrial) Natriuretic Peptide (Human, 1-28) (Porcine, Bovine, Canine) Ser-Leu-Arg-Arg-Ser- Ser-Cys-Phe-Gly-Gly- Arg-Met-Asp-Arg-Ile- Gly-Ala-Gln-Ser-Gly- Leu-Gly-Cys-Asn-Ser- Phe-Arg-Tyr (Disulfide bond between Cys7-Cys23) (M.W. 3080.4) C127H203N45O39S3 P. Needleman, E.H. Blaine, J.E. Greenwald, M.L. Michener,... | |
| A-Type (Atrial) Natriuretic Peptide (Human, 5-27) Ser-Ser-Cys-Phe-Gly- Gly-Arg-Met-Asp-Arg- Ile-Gly-Ala-Gln-Ser- Gly-Leu-Gly-Cys-Asn- Ser-Phe-Arg (Disulfide bond between Cys7-Cys23) (M.W. 2404.7) C97H154N34O32S3 T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. Sakakibara,... | |
| A-Type (Atrial) Natriuretic Peptide (Human, 5-28) Ser-Ser-Cys-Phe-Gly- Gly-Arg-Met-Asp-Arg- Ile-Gly-Ala-Gln-Ser- Gly-Leu-Gly-Cys-Asn- Ser-Phe-Arg-Tyr (Disulfide bond between Cys7-Cys23) (M.W. 2567.8) C106H163N35O34S3 S. Ueda, T. Sudoh, K. Fukuda, K. Kangawa, N. Minamino, and H. | |
| A-Type (Atrial) Natriuretic Peptide (Human, 7-28) Cys-Phe-Gly-Gly-Arg- Met-Asp-Arg-Ile-Gly- Ala-Gln-Ser-Gly-Leu- Gly-Cys-Asn-Ser-Phe- Arg-Tyr (M.W. 2393.7) C100H153N33O30S3 T.X. Watanabe, Y. Noda, N. Chino, Y. Nishiuchi, T. Kimura, S. Sakakibara, and M. Imai, Eur. | |
| A-Type (Atrial) Natriuretic Peptide (Rat, 3-28) -20 °C vial Arg-Arg-Ser-Ser-Cys- Phe-Gly-Gly-Arg-Ile- Asp-Arg-Ile-Gly-Ala- Gln-Ser-Gly-Leu-Gly- Cys-Asn-Ser-Phe-Arg- Tyr (Disulfide bond between Cys7-Cys23) (M.W. 2862.2) C119H189N43O36S2 [90984-99-9] N.G. Seidah, C. Lazure, M. Chretien, G. | |
| Ac-GrGDSPASSKGGGGSrL LLLLLr-Amide Trifluoroacetate Salt (M.W. 2308.69) C98H174N34O30 Hydrophobic Fibronectin Peptide W.S. Craig, S. Cheng, D.G. Mullen, J. Blevitt, and M.D. Pierschbacher, Biopolymers (Peptide Sci.), 37, 157 (1995). | |
| Ac-MBP (1-11) Ac-Ala-Ser-Gln-Lys-A rg-Pro-Ser-Gln-Arg-S er-Lys-OH (M.W. 1314.48) C53H95N21O18 Encephalitogenic Determinant S.D. Wolf, B.N. Dittel, F. Hardardottir, and C.A. Janeway, J. Exp. Med., 184, 2271 (1996). | |
| Ac-MBP (Human, Porcine, Rat 1-11) Ac-Ala-Ser-Gln-Lys-A rg-Pro-Ser-Gln-Arg-H is-Gly-OH (M.W. 1293.42) C52H88N22O17 Encephalitogenic Determinant J.E. Fenyk-Melody, A.E. Garrison, S.R. Brunnert, J.R. Weidner, F. Shen, B.A. Shelton, and J.S. Mudgett, J. Immunol.,... | |
| Ac-Ser-Tyr-Ser-Nle-G lu-His-D-Phe-Arg-Trp -Gly-Lys-Pro-Val-NH2 (M.W. 1646.88) C78H111N21O19 Melanocyte Stimulating Hormone Agonist / Melanocortin 1, 3, 4, and 5 Receptor Agonist T.K. Sawyer, P.J. Sanfilippo, V.J. Hruby, M.H. Engel, ClB. Heward, J.B. | |
| Adrenocorticotropic Hormone (Human, 1-24) Ser-Tyr-Ser-Met-Glu- His-Phe-Arg-Trp-Gly- Lys-Pro-Val-Gly-Lys- Lys-Arg-Arg-Pro-Val- Lys-Val-Tyr-Pro (M.W. 2933.4) C136H210N40O31S [16960-16-0] B. Riniker, P. Sieber, W. Rittel, and H. Zuber, Nature (New Biol.), 235, 114 (1972). (Original; Structure)... | |
| AGRP (Human, 86-132) Arg-Cys-Val-Arg-Leu- His-Glu-Ser-Cys-Leu- Gly-Gln-Gln-Val-Pro- Cys-Cys-Asp-Pro-Cys- Ala-Thr-Cys-Tyr-Cys- Arg-Phe-Phe-Asn-Ala- Phe-Cys-Tyr-Cys-Arg- Lys-Leu-Gly-Thr-Ala- Met-Asn-Pro-Cys-Ser- Arg-Thr (Disulfide bonds between Cys87-Cys102, Cys94-Cys108, Cys101-Cys119, Cys105-Cys129, and Cys110-Cys117) (M.W. 5347.2) C223H339N69O63S11 Melanocortin Receptor-3/4 Antagonist, Appetite Boosting... | |
| Ala-Asp-Cys-Lys-Tyr- Lys-Phe-Glu-Asn-Trp- Gly-Ala-Cys-Asp-Gly- Gly-Thr-Gly-Thr-Lys- Val-Arg-Gln-Gly-Thr- Leu-Lys-Lys-Ala-Arg- Tyr-Asn-Ala-Gln-Cys- Gln-Glu-Thr-Ile-Arg- Val-Thr-Lys-Pro-Cys- Thr-Pro-Lys-Thr-Lys- Ala-Lys-Ala-Lys-Ala- Lys-Lys-Gly-Lys-Gly- Lys-Asp (Disulfide bonds between Cys62-Cys94 and Cys72-Cys104) (M.W. 6788.8) C292H483N91O87S4 Heparin-Binding Growth/Differentiati on Factor Active-Domain (Neurite Outgrowth-Promoting Factor)... | |
| Ala-Gln-Glu-Pro-Val- Lys-Gly-Pro-Val-Ser- Thr-Lys-Pro-Gly-Ser- Cys-Pro-Ile-Ile-Leu- Ile-Arg-Cys-Ala-Met- Leu-Asn-Pro-Pro-Asn- Arg-Cys-Leu-Lys-Asp- Thr-Asp-Cys-Pro-Gly- Ile-Lys-Lys-Cys-Cys- Glu-Gly-Ser-Cys-Gly- Met-Ala-Cys-Phe-Val- Pro-Gln (Disulfide bonds between Cys16-Cys45, Cys23-Cys49, Cys32-Cys44, and Cys38-Cys53) (M.W. 5999.1) C254H416N72O75S10 Elastase-Specific Inhibitor from Human Skin O. Wiedow,... | |
| Ala-Glu-Glu-Glu-Thr- Ala-Gly-Gly-Asp-Gly- Arg-Pro-Glu-Pro-Ser- Pro-Arg-Glu-NH2 (M.W. 1882.9) C75H119N25O32 Pivotal Neuropeptide in Cardiovascular Regulation T. Hamakubo, M. Yoshida, K. Nakajima, T.X. Watanabe, R. Mosqueda-Garcia, and T. Inagami, Am. J. Physiol., 265, R1184... | |
| Alarin APAHRSSTFPKWVTKTERGR QPLRS Ala-Pro-Ala-His-Arg- Ser-Ser-Thr-Phe-Pro- Lys-Trp-Val-Thr-Lys- Thr-Glu-Arg-Gly-Arg- Gln-Pro-Leu-Arg-Ser (M.W. 2894.30) C127H205N43O35 Vasoactive Peptide / Splice Variant of Galanin-Like Peptide Synthetic Product 1) R. Lang, A.L. Gundlach, and B. Kofler, Pharmacol. | |
| alpha-Melanocyte Stimulating Hormone (Human, Porcine, Bovine, Rat, Mouse) Ac-Ser-Tyr-Ser-Met-G lu-His-Phe-Arg-Trp-G ly-Lys-Pro-Val-NH2 (M.W. 1664.9) C77H109N21O19S [581-05-5] T.H. Lee and A.B. Lerner, J. Biol. Chem., 221, 943 (1956). (Original; Porcine) R.A. Boissonnas,... | |
| Angiotensin (Human, 3-8) Val-Tyr-Ile-His-Pro- Phe (M.W. 774.91) C40H54N8O8 [23025-68-5] R.L. Haberl, P.J. Decker, and K.M. Einhäupl, Circ. Res., 68, 1621 (1991). (Biological Activitiy) J.W. Harding, V.I. Cook, A.V. Miller-Wing, J.M. | |
| Aoc-Trp-Met-Asp-Phe- NH2 (Aoc: t-Amyloxycarbonyl) (M.W. 710.84) C35H46N6O8S Y. Ishii and H. Shinozaki, Japan J. Pharmacol., 18, 93 (1968). (Pharmacol.). E. Jorpes and V. Mutt (eds.) Secretin, Cholecystokinin, Pancreozymin and Gastrin,... | |
| Arg-Pro-Hyp-Gly-Phe- Ser-Pro-Phe-Arg (M.W. 1076.2) C50H73N15O12 [37642-65-2] H. Kato, Y. Matsumura, and H. Maeda, FEBS Lett., 232, 252 (1988). (Original) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology,... | |
| Arg-Pro-Pro-Gly-Phe- Ser-Pro-Leu ⢠AcOH ⢠3H2O (M.W. 870.01 ⢠60.05 ⢠54.05) C41H63N11O10 ⢠CH3COOH ⢠3H2O [115035-45-5] Bradykinin B1-Receptor Antagonist D. Regoli, J. Barabe, and W.K. Park, Can. J. | |
| Arg-Pro-Pro-Gly-Phe- Ser-Pro-Leu (M.W. 870.01) C41H63N11O10 [64695-06-3] Bradykinin B1-Receptor Antagonist D. Regoli, J. Barabe, and W.K. Park, Can. J. Physiol. Pharmacol., 55, 855 (1977). (Original; pA2 ) E.G. Erdös (ed.) Bradykinin,... | |
| Arg-Pro-Pro-Gly-Phe- Ser-Pro-Phe ⢠AcOH ⢠3H2O (M.W. 904.02 ⢠60.05 ⢠54.05) C44H61N11O10 ⢠CH3COOH ⢠3H2O Bradykinin B1-Receptor Agonist D. Regoli, J. Barabe, and W.K. Park, Can. J. Physiol. | |
| Arg-Pro-Pro-Gly-Phe- Ser-Pro-Phe (M.W. 904.02) C44H61N11O10 [15958-92-6] Bradykinin B1-Receptor Agonist D. Regoli, J. Barabe, and W.K. Park, Can. J. Physiol. Pharmacol., 55, 855 (1977). (Original) E.G. Erdös (ed.) Bradykinin, Kallidin and... | |
| Arg-Pro-Pro-Gly-Phe- Ser-Pro-Tyr-Arg (M.W. 1076.2) C50H73N15O12 [32222-00-7] For Radioimmunoassay M.D. Nielsen, F. Nielsen, A.M. Kappelgaard, and J. Giese, Clinica Chimica Acta, 125, 145 (1982). (Radioimmunoassay) M.J. Fredrick, F.C. Abel, W.A. Rightsel,... | |
| Arg-Pro-Pro-Gly-Thi- Ser-D-Phe-Thi-Arg (Thi: L-Thienylalanine) (M.W. 1122.3) C50H71N15O11S2 [97825-07-5] Bradykinin B2-Receptor Antagonist R.J. Vavrek and J.M. Stewart, Peptides, 6, 161 (1985). (Original) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook of... | |
| Arg-Val-Tyr-Ile-His- Pro-Ile ⢠2AcOH ⢠4H2O (M.W. 897.08 ⢠120.10 ⢠72.06) C43H68N12O9 ⢠2CH3COOH ⢠4H2O [102029-49-2] Angiotensin III Selective Antagonist T. Kono, F. Ikeda, F. Oseko, H. Imura,... | |
| Arg-Val-Tyr-Ile-His- Pro-Ile (M.W. 897.08) C43H68N12O9 [52498-25-6] Angiotensin III Selective Antagonist T. Kono, F. Ikeda, F. Oseko, H. Imura, and J. Endo, J. Clin. Endocrinol. Metab., 52, 354 (1981). (Pharmacol.) I.H. | |
| Arg-Val-Tyr-Ile-His- Pro-Phe (M.W. 931.09) C46H66N12O9 [13602-53-4] W.B Campbell, S.N. Brooks, and W.A. Pettinger, Science, 184, 994 (1974). (Original) I.H. Page and F.M. Bumpus (eds.), Angiotensin, Handbook of Experimental Pharmacology, Vol. | |
| Arg-Val-Tyr-lle-His- Pro-Phe ⢠2AcOH ⢠4H2O (M.W. 931.09 ⢠120.11 ⢠72.06) C46H66N12O9 ⢠2CH3COOH ⢠4H2O [100900-06-9] W.B Campbell, S.N. Brooks, and W.A. Pettinger, Science, 184, 994 (1974). (Original)... | |
| Asn-Arg-Val-Tyr-Val- His-Pro-Phe ⢠AcOH ⢠4H2O (M.W. 1031.2 ⢠60.05 ⢠72.06) C49H70N14O11 ⢠CH3COOH ⢠4H2O I.H. Page and F.M. Bumpus (eds.), Angiotensin, Handbook of Experimental Pharmacology, Vol. 37,... | |
| Asn-Arg-Val-Tyr-Val- His-Pro-Phe (M.W. 1031.2) C49H70N14O11 [53-73-6] I.H. Page and F.M. Bumpus (eds.), Angiotensin, Handbook of Experimental Pharmacology, Vol. 37, Springer-Verlag, Berlin, 1974. (Review) M.J. Peach, Physiol. Rev., 57, 313 (1997). | |
| Asp-Ala-Glu-Phe-Arg- His-Asp-Ser-Gly-Tyr- Glu-Val-His-His-Gln- Lys (M.W. 1955.0) C84H119N27O28 Blocker for Plaque-Induced Microgliosis / Reducer for Brain Inflammation D. Giulian, L.J. Haverkamp, J. Yu, W. Karshin, D. Tom, J. Li, A. Kazanskaia,... | |
| Asp-Arg-Val-Tyr-Ile- His-Pro-Phe ⢠AcOH ⢠4H2O (M.W. 1046.2 ⢠60.05 ⢠72.06) C50H71N13O12 ⢠CH3COOH ⢠4H2O K. Arakawa, M. Nakatani, A. Minohara, and M. Nakamura, Biochem. J., 104, 900... | |
| Asp-Arg-Val-Tyr-Ile- His-Pro-Phe (M.W. 1046.2) C50H71N13O12 [4474-91-3] K. Arakawa, M. Nakatani, A. Minohara, and M. Nakamura, Biochem. J., 104, 900 (1967). (Original) I.H. Page and F.M. Bumpus (eds.), Angiotensin, Handbook of... | |
| Asp-Arg-Val-Tyr-Ile- His-Pro-Phe-His-Leu- Leu-Tyr (M.W. 1572.8) C77H109N19O17 New Member of Angiotensin Family S. Nagata, J. Kato, K. Sasaki, N. Minamino, T. Eto, and K. Kitamura, Biochem. and Biophys. Res. Commun., 350,... | |
| Asp-Arg-Val-Tyr-Val- His-Pro-Phe ⢠AcOH ⢠4H2O (M.W. 1032.2 ⢠60.05 ⢠72.06) C49H69N13O12 ⢠CH3COOH ⢠4H2O [5649-07-0] D.F. Elliot and W.S. Peart, Nature, 177, 527 (1956). (Original; Heterogenous Renin)... | |
| Asp-Arg-Val-Tyr-Val- His-Pro-Phe (M.W. 1032.2) C49H69N13O12 [58-49-1] D.F. Elliot and W.S. Peart, Nature, 177, 527 (1956). (Original; Heterogenous Renin) H. Akagi, T. Hayashi, T. Nakayama, T. Nakajima, T.X. Watanabe, and H. | |
| Asp-Arg-Val-Tyr-Val- His-Pro-Phe-His-Leu ⢠AcOH ⢠5H2O - (M.W. 1282.4 ⢠60.05 ⢠90.08) C61H87N17O14 ⢠CH3COOH ⢠5H2O D.F. Elliott and W.S. Peart, Biochem. J., 65, 246 (1957). (Original; Heterogenous... | |
| Asp-Arg-Val-Tyr-Val- His-Pro-Phe-His-Leu (M.W. 1282.4) C61H87N17O14 [484-43-5] D.F. Elliott and W.S. Peart, Biochem. J., 65, 246 (1957). (Original; Heterogenous Renin) H. Akagi, T. Hayashi, T. Nakayama, T. Nakajima, T.X. Watanabe, and... | |
| Asp-Ser-His-Ala-Lys- Arg-His-His-Gly-Tyr- Lys-Arg-Lys-Phe-His- Glu-Lys-His-His-Ser- His-Arg-Gly-Tyr (M.W. 3036.3) C133H195N51O33 [104339-66-4] Parotid Histidine-rich Protein F.G. Oppenheim, T. Xu, F.M. McMillian, S.M. Levitz, R.D. Diamond, G.D. Offner, and R.F. Troxier, J. Biol. Chem.,... | |
| AYPGKF Acid form of PAR-3674-PI E.A. Lidington, R. Steinberg, A.R. Kinderlerer, R.C. Landis, M. Ohba, A. Samarel, D.O. Haskard, and J.C. Mason, Am J Physiol Cell Physiol, 289, C1437 (2005). | |
| AYPGKF-Amide (M.W. 680.81) C34H48N8O7 Selective Protease-Activated Receptor 4 (PAR4) Agonist M.D. Hollenberg, M. Saifeddine, B. Al-Ani, and Y. Gui, Can. J. Physiol. Pharmacol., 77, 458 (1999). T.R. Faruqi, E.J. Weiss,... | |
| B-Type (Brain) Natriuretic Peptide (Porcine, 1-26) Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: BNP-26 (Porcine)-TG (TG: Bovine Thyroglobulin) Specificity: BNP-26 (Porcine) 100% BNP (Porcine, 20-26)... | |
| B-Type (Brain) Natriuretic Peptide-26 (Porcine) Asp-Ser-Gly-Cys-Phe- Gly-Arg-Arg-Leu-Asp- Arg-lle-Gly-Ser-Leu- Ser-Gly-Leu-Gly-Cys- Asn-Val-Leu-Arg-Arg- Tyr (Disulfide bond between Cys4-Cys20) (M.W. 2869.2) C120H198N42O36S2 [114547-28-3] T. Sudoh, K. Kangawa, N. Minamino, and H. Matsuo, Nature, 332,... | |
| B-Type (Brain) Natriuretic Peptide-32 (Human) Ser-Pro-Lys-Met-Val- Gln-Gly-Ser-Gly-Cys- Phe-Gly-Arg-Lys-Met- Asp-Arg-Ile-Ser-Ser- Ser-Ser-Gly-Leu-Gly- Cys-Lys-Val-Leu-Arg- Arg-His (Disulfide bond between Cys10-Cys26) (M.W. 3464.0) C143H244N50O42S4 T. Sudoh, K. Maekawa, M. Kojima, N. Minamino, K. Kangawa, and... | |
| B-Type (Brain) Natriuretic Peptide-32 (Rat) Asn-Ser-Lys-Met-Ala- His-Ser-Ser-Ser-Cys- Phe-Gly-Gln-Lys-Ile- Asp-Arg-Ile-Gly-Ala- Val-Ser-Arg-Leu-Gly- Cys-Asp-Gly-Leu-Arg- Leu-Phe (Disulfide bond between Cys10-Cys26) (M.W. 3452.9) C146H239N47O44S3 [123337-89-3] M. Kojima, N. Minamino, K. Kangawa, and H. Matsuo, Biochem. | |
| B-Type (Brain) Natriuretic Peptide-45 (Rat) Ser-Gln-Asp-Ser-Ala- Phe-Arg-Ile-Gln-Glu- Arg-Leu-Arg-Asn-Ser- Lys-Met-Ala-His-Ser- Ser-Ser-Cys-Phe-Gly- Gln-Lys-Ile-Asp-Arg- Ile-Gly-Ala-Val-Ser- Arg-Leu-Gly-Cys-Asp- Gly-Leu-Arg-Leu-Phe (Disulfide bond between Cys23-Cys39) (M.W. 5040.7) C213H349N71O65S3 [133448-20-1] M. Aburaya, J. Hino, N. Minamino, K. Kangawa,... | |
| beta-A-Type (Atrial) Natriuretic Peptide Antiparallel Dimer of ANP (Human, 1-28) Ser-Leu-Arg-Arg-Ser- Ser-Cys7(1)-Phe-Gly- Gly-Arg-Met-Asp-Arg- lle-Gly-Ala-Gln-Ser- Gly-Leu-Gly-Cys231-A sn-Ser-Phe-Arg-Tyr Tyr-Arg-Phe-Ser-Asn- Cys23(1)-Gly-Leu-Gly -Ser-Gln-Ala-Gly-lle -Arg-Asp-Met-Arg-Gly -Gly-Phe-Cys71-Ser-S er-Arg-Arg-Leu-Ser (Disulfide bonds betwen Cys7-Cys23(1) and Cys7(1)-Cys23(1)) (M.W. 6160.9)... | |
| beta-Lipotropin (61-76) Tyr-Gly-Gly-Phe-Met- Thr-Ser-Glu-Lys-Ser- Gln-Thr-Pro-Leu-Val- Thr (M.W. 1745.9) C77H120N18O26S [59004-96-5] N. Ling, R. Burgus, and R. Guillemin, Proc. Natl. Acad. Sci. USA, 73, 3942 (1976). (Original; Porcine)A. Goldstein, Ann. N.Y. | |
| beta-Lipotropin (61-77) Tyr-Gly-Gly-Phe-Met- Thr-Ser-Glu-Lys-Ser- Gln-Thr-Pro-Leu-Val- Thr-Leu (M.W. 1859.1) C83H131N19O27S N. Ling, R. Burgus, and R. Guillemin, Proc. Natl. Acad. Sci. USA, 73, 3942 (1976). (Original; Porcine) A. Goldstein, Ann. N.Y. | |
| beta-Lipotropin (Human, 61-91) Tyr-Gly-Gly-Phe-Met- Thr-Ser-Glu-Lys-Ser- Gln-Thr-Pro-Leu-Val- Thr-Leu-Phe-Lys-Asn- Ala-Ile-Ile-Lys-Asn- Ala-Tyr-Lys-Lys-Gly- Glu (M.W. 3465.0) C158H251N39O46S [61214-51-5] C.H. Li and D. Chung, Nature, 260, 622 (1976). (Original; Human) C.H. Li, D. Yamashiro, L.-F. | |
| Bovine Adrenal Medulla Dodecapeptide Tyr-Gly-Gly-Phe-Met- Arg-Arg-Val-Gly-Arg- Pro-Glu (M.W. 1424.6) C62H97N21O16S [75513-71-2] K. Mizuno, N. Minamino, K. Kangawa, and H. Matsuo, Biochem. Biophys. Res. Commun., 95, 1482 (1980). (Original) | |
| c(RADfC) (M.W. 592.68) C25H36N8O7S Control for PCI-3686-PI | |
| c(RADfK) (M.W. 617.71) C28H43N9O7 Negative Control RGD Peptide for PCI-3661-PI P.K. Dubey, V. Mishra, S. Jain, S. Mahor, and S.P. Vyas, J. Drug Targeting, 12, 257 (2004). | |
| c(RADfV) (M.W. 588.68) C27H40N8O7 Negative Control for ICA-4304 M. Friedlander, C.L. Theesfeld, M. Sugita, M. Fruttiger, M.A. Thomas, S. Chang, and D.A. Cheresh, PNAS, 93, 9764 (1996). | |
| c(RADyC) C25H36N8O8S | |
| c(RADyK) (M.W. 633.71) C28H43N9O8 Control Peptide of cyclo (Arg-Gly-Asp-D-Tyr-L ys) (PCI-3662-PI) | |
| c(RGDfC) (M.W. 578.65) C24H34N8O7S RGD Tumor Targeting Peptide (linker additions via Cys) (May require further derivatization before use) C. Pattillo, F. Sari-Sarraf, R. Nallamothu, B. Moore, G. Wood, and M. | |
| c(RGDfE) (M.W. 604.63) C26H36N8O9 RGD Peptide for Radiolabeling and Imaging (Requires further derivatization before use) G. Thumshirn, U. Hersel, S.L. Goodman, and H. Kessler, Chem. Eur. J., 9, 2717 (2003). | |
| c(RGDfK(Biotin-PEG-P EG)) where PEG = 8-Amino-3,6-Dioxaoct anoic Acid (M.W. 1120.30) C49H77N13O15S RGD Peptide equipped with a biotin reporting tag and PEG spacers for more efficient binding to lipid surfaces (Requires... | |
| c(RGDfK(PEG-PEG)) where PEG = 8-Amino-3,6-Dioxaoct anoic Acid (M.W. 894.0) C39H63N11O13 RGD Peptide equipped with PEG spacers for more efficient binding to lipid surfaces (Requires further derivatization before use) P. Holig,... | |
| c(RGDfK) (M.W. 603.68) C27H41N9O7 alphavbeta3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide (Requires further derivatization before use) M. Kantlehner, P. Schaffner, D. Finsinger, J. Meyer, A. Jonczyk, B. Diefenbach,... | |
| c(RGDfK) Trifluoroacetate Salt (M.W. 603.68) C27H41N9O7 RGD Tumor Targeting Peptide (Requires further derivatization before use) M. Kantlehner, P. Schaffner, D. Finsinger, J. Meyer, A. Jonczyk, B. Diefenbach, B. Nies,G. Hozemann,... | |
| c(RGDyC) (M.W. 594.65) C24H34N8O8S | |
| c(RGDyE) (M.W. 620.62) C26H36N8O10 RGD Peptide for Radiolabeling (Requires further derivatization before use) | |
| c(RGDyK) (M.W. 619.68) C27H41N9O7 alphavbeta3 Integrin Binding RGD Peptide RGD Tumor Targeting and Tumor Imaging Peptide (Requires further derivatization before use) R. Haubner, H.J. Wester, F. Burkhart, R. Senekowitsch-Schmidt ky,... | |
| C-Type Natriuretic Peptide-22 (Human) (Porcine, Rat, Mouse) Gly-Leu-Ser-Lys-Gly- Cys-Phe-Gly-Leu-Lys- Leu-Asp-Arg-Ile-Gly- Ser-Met-Ser-Gly-Leu- Gly-Cys (Disulfide bond between Cys6-Cys22) (M.W. 2197.6) C93H157N27O28S3 [127869-51-6] T. Sudoh, N. Minamino, K. Kangawa, and H. Matsuo, Biochem. | |
| C-type Natriuretic Peptide-22 (Human) Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: CNP-22 (Human)-TG (TG: Bovine Thyrogloblin) Specificity: CNP-22 (Human) 100% CNP-53 (Porcine, Rat) 100% CNP-53... | |
| C-Type Natriuretic Peptide-53 (Human) Asp-Leu-Arg-Val-Asp- Thr-Lys-Ser-Arg-Ala- Ala-Trp-Ala-Arg-Leu- Leu-Gln-Glu-His-Pro- Asn-Ala-Arg-Lys-Tyr- Lys-Gly-Ala-Asn-Lys- Lys-Gly-Leu-Ser-Lys- Gly-Cys-Phe-Gly-Leu- Lys-Leu-Asp-Arg-Ile- Gly-Ser-Met-Ser-Gly- Leu-Gly-Cys (Disulfide bond between Cys37-Cys53) (M.W. 5801.7) C251H417N81O71S3 [141294-77-1] Y. Tawaragi, K. Fuchimura, S. Tanaka, N. | |
| C-Type Natriuretic Peptide-53 (Porcine, Rat) Asp-Leu-Arg-Val-Asp- Thr-Lys-Ser-Arg-Ala- Ala-Trp-Ala-Arg-Leu- Leu-His-Glu-His-Pro- Asn-Ala-Arg-Lys-Tyr- Lys-Gly-Gly-Asn-Lys- Lys-Gly-Leu-Ser-Lys- Gly-Cys-Phe-Gly-Leu- Lys-Leu-Asp-Arg-Ile- Gly-Ser-Met-Ser-Gly- Leu-Gly-Cys (Disulfide bond between Cys37-Cys53) (M.W. 5796.7) C251H414N82O70S3 N. Minamino, K. Kangawa, and H. Matsuo,... | |
| c[RADfK(Ac-SCH2CO)] (M.W. 733.85) C32H47N9O9S Control for PCI-3699-PI | |
| c[RGDfK (Ac-SCH2CO)] (M.W. 719.82) C31H45N9O9S RGD Peptide equipped with thioacetyl group for linking to liposomes (May require further derivatization and deprotection before use) R.J. Kok, A.J. Schraa, E.J. Bos, H.E. | |
| c[RGDfK(Biotin)] (M.W. 829.98) C37H55N11O9S RGD Peptide equipped with a biotin reporting tag D. Boturyn, J.-L. Coll, E. Garager, M.-C. Favrot, and P. Dumy, JACS, 126, 5730 (2004). | |
| Calcitonin Gene Related Peptide (Human) alpha-CGRP (Human) Ala-Cys-Asp-Thr-Ala- Thr-Cys-Val-Thr-His- Arg-Leu-Ala-Gly-Leu- Leu-Ser-Arg-Ser-Gly- Gly-Val-Val-Lys-Asn- Asn-Phe-Val-Pro-Thr- Asn-Val-Gly-Ser-Lys- Ala-Phe-NH2 (Disulfide bond between Cys2-Cys7) (M.W. 3789.3) C163H267N51O49S2 [90954-53-3] H.R. Morris, M. Panico, T. Etienne, J. | |
| Calcitonin Gene Related Peptide (Human) alpha-CGRP (Human) H.R. Morris, M. Panico, T. Etienne, J. Tippins, S.l. Girgis, and I. Maclntyre, Nature, 308, 746 (1984). (Original) ⢠This compound is distributed... | |
| Calcitonin Gene Related Peptide (Human) Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: CGRP (Human)-TG (TG: Bovine Thyroglobulin) Specificity: CGRP (Human) 100% CGRP II (Human) 20%... | |
| Calcitonin Gene Related Peptide (Human, 8-37) alpha-CGRP (Human, 8-37) Val-Thr-His-Arg-Leu- Ala-Gly-Leu-Leu-Ser- Arg-Ser-Gly-Gly-Val- Val-Lys-Asn-Asn-Phe- Val-Pro-Thr-Asn-Val- Gly-Ser-Lys-Ala-Phe- NH2 (M.W. 3125.6) C139H230N44O38 [119911-68-1] Calcitonin Gene Related Peptide (CGRP) Antagonist T. Chiba, A. Yamaguchi,... | |
| Calcitonin Gene Related Peptide (Rat) alpha-CGRP (Rat) S.G. Amara, V. Jonas, M.G. Rosenfeld, E.S. Ong, and R.M. Evans, Nature, 298, 240 (1982). (Original) M.G. Rosenfeld, J.-J. Mermod, S.G. Amara, L.W. | |
| CCK-4 Trp-Met-Asp-Phe-NH2 ⢠HCI ⢠H2O (M.W. 596.70 ⢠36.46 ⢠18.02) C29H36N6O6S ⢠HCI ⢠H2O [5609-49-4] J.F. Rehfeld, L.l. Larsson, N.R. Goltermann, T.W. Schwartz, J.J. Holst, S.L. Jensen,... | |
| CCK-8 (Non-Sulfated Form) (Ammonium Form) Asp-Tyr-Met-Gly-Trp- Met-Asp-Phe-NH2 (M.W. 1063.2) C49H62N10O13S2 [25679-24-7] M.A. Ondetti, J. Pluscec, E.F. Sabo, J.T. Sheehan, and N. Williams, J. Am. Chem. Soc., 92, 195 (1970). (Chem. | |
| CCK-8 (Sulfated Form) (Ammonium Form) Asp-Tyr(SO3H)-Met-Gl y-Trp-Met-Asp-Phe-NH 2 (M.W. 1143.3) C49H62N10O16S3 [25126-32-3] M.A. Ondetti, J. Pluscec, E.F. Sabo, J.T. Sheehen, and N. Williams, J. Am. Chem. Soc., 92, 195 (1970). | |
| CGRP (Rat)* PCG-4163-v Calcitonin Gene Related Peptide (Rat) a-CGRP (Rat) Ser-Cys-Asn-Thr-Ala- Thr-Cys-Val-Thr-His- Arg-Leu-Ala-Gly-Leu- Leu-Ser-Arg-Ser-Gly- Gly-Val-Val-Lys-Asp- Asn-Phe-Val-Pro-Thr- Asn-Val-Gly-Ser-Glu- Ala-Phe-NH2 (Disulfide bond between Cys2-Cys7) (M.W. 3806.2) C162H262N50O52S2 S.G. Amara, V. Jonas, M.G. | |
| CINC-1/gro (Rat) Cytokine-Induced Neutrophil Chemoattractant-1/ growth-related oncogene (Rat) Ala-Pro-Val-Ala-Asn- Glu-Leu-Arg-Cys-Gln- Cys-Leu-Gln-Thr-Val- Ala-Gly-Ile-His-Phe- Lys-Asn-Ile-Gln-Ser- Leu-Lys-Val-Met-Pro- Pro-Gly-Pro-His-Cys- Thr-Gln-Thr-Glu-Val- Ile-Ala-Thr-Leu-Lys- Asn-Gly-Arg-Glu-Ala- Cys-Leu-Asp-Pro-Glu- Ala-Pro-Met-Val-Gln- Lys-Ile-Val-Gln-Lys- Met-Leu-Lys-Gly-Val- Pro-Lys (Disulfide bonds between Cys9-Cys35 and Cys11-Cys51) (M.W. | |
| Cocaine-and Amphetamine-Regulate d Transcript (Human, 55-102) Ile-Pro-Ile-Tyr-Glu- Lys-Lys-Tyr-Gly-Gln- Val-Pro-Met-Cys-Asp- Ala-Gly-Glu-Gln-Cys- Ala-Val-Arg-Lys-Gly- Ala-Arg-Ile-Gly-Lys- Leu-Cys-Asp-Cys-Pro- Arg-Gly-Thr-Ser-Cys- Asn-Ser-Phe-Leu-Leu- Lys-Cys-Leu (Disulfide bonds between Cys68-Cys86, Cys74-Cys94, and Cys88-Cys101) (M.W. 5245.2) C225H365N65O65S7 [214050-22-3] Food-Intake Inhibitor P. | |
| Cocaine-and Amphetamine-Regulate d Transcript (Rat, 55-102) Ile-Pro-Ile-Tyr-Glu- Lys-Lys-Tyr-Gly-Gln- Val-Pro-Met-Cys-Asp- Ala-Gly-Glu-Gln-Cys- Ala-Val-Arg-Lys-Gly- Ala-Arg-Ile-Gly-Lys- Leu-Cys-Asp-Cys-Pro- Arg-Gly-Thr-Ser-Cys- Asn-Ser-Phe-Leu-Leu- Lys-Cys-Leu (Disulfide bonds between Cys68-Cys86, Cys74-Cys94, and Cys88-Cys101) (M.W. 5259.2) C226H367N65O65S7 [209615-79-2] Food-Intake Inhibitor P. | |
| Corticotropin Releasing Factor (Human) Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: CRF (Human)-TG (TG: Bovine Thyroglobulin) Specificity: CRF (Human) 100% CRF (Human, 31-42) 35% CRF... | |
| Corticotropin-Releas ing Factor (Human, Rat) Ser-Glu-Glu-Pro-Pro- Ile-Ser-Leu-Asp-Leu- Thr-Phe-His-Leu-Leu- Arg-Glu-Val-Leu-Glu- Met-Ala-Arg-Ala-Glu- Gln-Leu-Ala-Gln-Gln- Ala-His-Ser-Asn- Arg-Lys-Leu-Met-Glu- Ile-Ile-NH2 (M.W. 4757.5) C208H344N60O63S2 [86784-80-7] J. Spiess, J. Rivier, and W. Vale, Biochemistry, 22, 4341 (1983). (Original; | |
| Corticotropin-Releas ing Factor (Ovine) Ser-Gln-Glu-Pro-Pro- Ile-Ser-Leu-Asp-Leu- Thr-Phe-His-Leu-Leu- Arg-Glu-Val-Leu-Glu- Met-Thr-Lys-Ala-Asp- Gln-Leu-Ala-Gln-Gln- Ala-His-Ser-Asn-Arg- Lys-Leu-Leu-Asp-Ile- Ala-NH2 (M.W. 4670.3) C205H339N59O63S CW. Vale, J. Spiess, C. RivIer, and J. Rivier, Science, 213, 1394 (1981). C.L. | |
| Corticotropin-Releas ing Factor (Ovine) Ser-Gln-Glu-Pro-Pro- Ile-Ser-Leu-Asp-Leu- Thr-Phe-His-Leu-Leu- Arg-Glu-Val-Leu-Glu- Met-Thr-Lys-Ala-Asp- Gln-Leu-Ala-Gln-Gln- Ala-His-Ser-Asn-Arg- Lys-Leu-Leu-Asp-Ile- Ala-NH2 (M.W. 4670.3) C205H339N59O63S W. Vale, J. Spiess, C. RivIer, and J. Rivier, Science, 213, 1394 (1981). C.L. | |
| CST-14 (Rat) Pro-Cys-Lys-Asn-Phe- Phe-Trp-Lys-Thr-Phe- Ser-Ser-Cys-Lys (Disulfide bond between Cys2-Cys13) (M.W. 1721.0) C81H113N19O19S2 Neuronal Depressant and Sleep-Modulating Peptide L. De Lecea, J.R. Criado, O. Prospero-Garcia, K.M. Gautvik, P. Schweitzer, P.E. Danielson,... | |
| cyclo (Arg-Gly-Glu-D-Phe-L ys) c(RGEfK) (M.W. 617.71) C28H43N9O7 | |
| cyclo (Leu-Gly) (M.W. 170.21 ) C8H14N2O2 [5845-67-0] R. Walter, R. Ritzmann, H.N. Bhargava, and L.B. Flexner, Proc. Natl. Acad. Sci. USA, 76, 518 (1979). (Original) | |
| cyclo [Arg-Ala-Asp-D-Phe-L ys(PEG-PEG)] c[RGDfK(PEG-PEG)] (M.W. 908.03) C40H65N11O13 Control Peptide for PCI-3696-PI | |
| cyclo [FLLRK(Dap)] Thrombin Receptor Activating Peptide K. Alexopoulos, D. Panagiotopoulos, T. Mavromoustakos, P. Fatseas, M.C. Paredes-Carbajal, D. Mascher, S. Mihailescu, and J. Matsoukas, J. Med. Chem., 44. 328 (2001). | |
| cyclo [RGDfK(H-Ser)] (M.W. 690.76) C30H46N10O9 alphavbeta3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide (Requires further derivatization before use) | |
| Cys-Gly-Asn-Leu-Ser- Thr-Cys-Met-Leu-Gly- Thr-Tyr-Thr-Gln-Asp- Phe-Asn-Lys-Phe-His- Thr-Phe-Pro-Gln-Thr- Ala-Ile-Gly-Val-Gly- Ala-Pro-NH2 (Disulfide bond between Cys1-Cys7) (M.W. 3417.8) C151H226N40O45S3 [21215-62-3] R. Neher, B. Riniker, W. Rittel, and H. Zuber, Helv. Chim. Acta, 51, 1900 (1968). | |
| Cys-Ser-Cys-Ser-Ser- Leu-Met-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp-Val-Asn-Thr-Pro- Glu-Arg- Val-Val-Pro-Tyr-Gly- Leu-Gly-Ser-Pro-Ser- Arg-Ser (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 4389.0) C192H292N50O58S5 T. Sakurai, M. Yanagisawa, A. Inoue, U.S. Ryan, S. Kimura, Y. Mitsui,... | |
| Cys-Ser-Cys-Ser-Ser- Leu-Met-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp-Val-Asn-Thr-Pro- Glu-His-Ile-Val-Pro- Tyr-Gly-Leu-Gly-Ser- Pro-Ser-Arg-Ser (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 4384.0) C193H289N49O58S5 [120796-99-8] M. Yanagisawa and T. Masaki, Trends Pharmacol. Sci., 10, 374 (1989). (Review)... | |
| Cys-Ser-Cys-Ser-Ser- Leu-Met-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp-Val-Asn-Thr-Pro- Glu-His-Ile-Val-Pro- Tyr-Gly-Leu-Gly-Ser- Pro-Ser-Arg-Ser (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 4384.0) C193H289N49O58S5 [120796-99-8] M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui,... | |
| Cys-Ser-Cys-Ser-Ser- Leu-Met-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp-Val-Asn-Thr-Pro- Glu-His-Val-Val-Pro- Tyr (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 3628.2) C162H236N38O47S5 [133972-52-8] A. Nakao, F. Kishi, K. Minami, H. Wakabayashi, Y. Nakaya, and H. Kido,... | |
| Cys-Ser-Cys-Ser-Ser- Leu-Met-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp-Val-Asn-Thr-Pro- Glu-His-Val-Val-Pro- Tyr-Gly-Leu-Gly-Ser- Pro-Arg-Ser (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 4282.9) C189H282N48O56S5 [120796-97-6] M. Yanagisawa and T. Masaki, Trends Pharmacol. Sci., 10, 374 (1989). (Review)... | |
| Cys-Ser-Cys-Ser-Ser- Leu-Met-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp-Val-Asn-Thr-Pro- Glu-His-Val-Val-Pro- Tyr-Gly-Leu-Gly-Ser- Pro-Arg-Ser (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 4282.9) C189H282N48O56S5 [120796-97-6] Y. Itoh, M. Yanagisawa, S. Ohkubo, C. Kimura, T. Kosaka, A. Inoue,... | |
| Cys-Ser-Cys-Ser-Ser- Trp-Leu-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp-Val-Asn-Thr-Pro- Glu-Gln-Thr-Ala-Pro- Tyr-Gly-Leu-Gly-Asn- Pro-Pro-Arg (M.W. 4339.9) C194H281N49O57S4 T. Kosaka, N. Suzuki, Y. Ishibashi, H. Matsumato, Y. Itoh, S. Ohkubo, K. Ogi, C. Kitada, H. Onda, and... | |
| Cys-Thr-Cys-Phe-Thr- Tyr-Lys-Asp-Lys-Glu- Cys-Val-Tyr-Tyr-Cys- His-Leu-Asp-Ile-Ile- Trp-Ile-Asn-Thr-Pro- Glu-Gln-Thr-Val-Pro- Tyr-Gly-Leu-Ser-Asn- His-Arg-Gly-Ser-Leu- Arg-NH2 (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 4863.5) C217H322N58O62S4 R. Shiba, T. Sakural, G. Yamada, H. Morimoto, A. Salto, T. Masaki,... | |
| Cys-Thr-Cys-Phe-Thr- Tyr-Lys-Asp-Lys-Glu- Cys-Val-Tyr-Tyr-Cys- His-Leu-Asp-Ile-Ile- Trp-Ile-Asn-Thr-Pro- Glu-Gln-Thr-Val-Pro- Tyr-Gly-Leu-Ser-Asn- Tyr-Arg-Gly-Ser-Phe- Arg-NH2 (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 4923.5) C223H322N56O63S4 K.D. Bloch, R.L. Eddy, T.B. Shows, and T. Quertermous, J. Biol. Chem.,... | |
| Cytokine-Induced Neutrophil Chemoattractant / Growth-Related Oncogene (Rat) Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: CINC/gro (Rat, 1-72) (Carrier-free) Specificity: CINC/gro (Rat, 1-72) 100% [Cys(Acm)9,11]-CINC/ gro... | |
| D-Arg-Arg-Pro-Hyp-Gl y-Thi-Ser-D-Phe-Thi- Arg ⢠2AcOH ⢠4H2O (Thi: L-Thienylalanine) (M.W. 1294.5 ⢠120.11 ⢠72.06) C56H83N19O13S2 ⢠2CH3COOH ⢠4H2O Bradykinin B2-Receptor Antagonist M. Schachter, Y. Uchida, D.J. Longridge, T. | |
| D-Arg-Arg-Pro-Hyp-Gl y-Thi-Ser-D-Phe-Thi- Arg (Thi: L-Thienylalanine) (M.W. 1294.5) C56H83N19O13S2 [103412-42-6] Bradykinin B2-Receptor Antagonist M. Schachter, Y. Uchida, D.J. Longridge, T. Labedz, E.T. Whalley, R.J. Vavrek, and J.M. Stewart, Br. J. Pharmacol.,... | |
| Delta Sleep-Inducing Peptide (DSIP) Trp-Ala-Gly-Gly-Asp- Ala-Ser-Gly-Glu (M.W. 848.81) C35H48N10O15 [62568-57-4] G.A. Schoenenberger and M. Monnier, Proc. Natl. Acad. Sci., USA., 74, 1282 (1977). (Original) M. Monnier, L. Dudler, R. Gachter,... | |
| Delta-(L-alpha-amino adipyl)-L-Cysteinyl- Bis-D-Valine (M.W. 724.27) | |
| Des-Acyl Ghrelin (Human) Des-n-Octanoyl Ghrelin (Human) (Trifluoroacetate Form) Gly-Ser-Ser-Phe-Leu- Ser-Pro-Glu-His-Gln- Arg-Val-Gln-Gln-Arg- Lys-Glu-Ser-Lys-Lys- Pro-Pro-Ala-Lys-Leu- Gln-Pro-Arg (M.W. 3244.7) C141H235N47O41 Des-Octanoylated Ghrelin with Distinct Effect on Food Intake M. Kojima, H. Hosoda, Y. | |
| Des-Acyl Ghrelin (Rat) Des-n-Octanoyl Ghrelin (Rat) (Trifluoroacetate Form) Gly-Ser-Ser-Phe-Leu- Ser-Pro-Glu-His-Gln- Lys-Ala-Gln-Gln-Arg- Lys-Glu-Ser-Lys-Lys- Pro-Pro-Ala-Lys-Leu- Gln-Pro-Arg (M.W. 3188.6) C139H231N45O41 Des-Octanoylated Ghrelin with Distinct Effect on Food Intake M. Kojima, H. Hosoda, Y. | |
| Des-Asp1-[Ala1]-Angi otensin II (Human) ARVYIHPF (M.W. 1002.19) C49H71N13O10 Vasoconstrictive Peptide / Angiotensin Peptide V. Jankowski, R. Vanholder, M. van der Giet, M. Tölle, S. Karadogan, J. Gobom, J. Furkert, A. | |
| Disulfide bond between Cys2 and Cys11 Melanin Concentrating Hormone Receptor 1 Antagonist M.A. Bednarek, C. Tan, D.L. Hreniuk, O.C. Palyha, D.J. MacNeil, L.H.Y. Van der Ploeg, A.D. Howard, and S.D. | |
| Disulfide bond between Cys2 and Cys9 Ava = Aminovaleric acid Melanin Concentrating Hormone Receptor 1 Antagonist M.A. Bednarek, D.L. Hreniuk, C. Tan, O.C. Palyha, D.J. MacNeil, L.H. Y. Van der... | |
| DOTA-E-[c(RGDfK)2] (M.W. 1704.88) C75H113N23O23 alphavbeta3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide for Radiolabelling (Requires further derivatization before use) M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink,... | |
| E-[c(RGDfK)2] (M.W. 1318.47) C59H87N19O16 alphavbeta3 Integrin Binding RGD Peptide RGD Tumor Targeting Peptide (Requires further derivatization before use) M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards,... | |
| E-[c(RGDfK)2] Trifluoroacetate Salt (M.W. 1318.47)C59H87N19O16 RGD Tumor Targeting and Tumor Imaging Peptide (Requires further derivatization before use) M.L. Janssen, W.J. Oyen, I. Dijkgraaf, L.F. Massuger, C. Frielink, D.S. Edwards, M. | |
| Enzymatically Derived from Porcine Insulin A-chain:Gly-Ile-Val- Glu-Gln-Cys-Cys-Thr- Ser-Ile-Cys-Ser-Leu- Tyr-Gln-Leu-Glu-Asn- Tyr-Cys-Asn B-chain:Phe-Val-Asn- Gln-His-Leu-Cys-Gly- Ser-His-Leu-Val-Glu- Ala-Leu-Tyr-Leu-Val- Cys-Gly-Glu-Arg-Gly- Phe-Phe-Tyr-Thr-Pro- Lys-Thr (Disulfide bonds between CysA6-CysA11,CysA7-C ysB7, and CysA20-CysB19) (M.W. 5807.6) C257H383N65O77S6 [11061-68-0] K. Morihara,... | |
| Fibronectin Active Fragment (RGDS) Arg-Gly-Asp-Ser ⢠½AcOH ⢠2H2O (M.W. 433.42 ⢠30.03 ⢠36.03) C15H27N7O8 ⢠½CH3COOH ⢠2H2O M.D. Piershbacher and E. Ruoslahti, Nature, 309, 30 (1984). (Original)... | |
| Fibronectin Active Fragment (RGDS) Arg-Gly-Asp-Ser (M.W. 433.42) C15H27N7O8 [91037-65-9] M.D. Piershbacher and E. Ruoslahti, Nature, 309, 30 (1984). (Original) D.M. Haverstick, J.F. Cowan, K.M. Yamada, and S.A. Santoro, Blood, 66,... | |
| FLLRN Protease-Activated Receptor 1 (PAR1 ) Antagonist Acid Form R.R. Vassallo, Jr, T. Kieber-Emmons, K. Cichowski, and .L.F Brass, J. Biol. Chem., 267, 6081 (1992). | |
| For-Met-Leu-Phe FMLP (M.W. 437.55) C21H31N3O5S [59880-97-6] L.T. Williams, R. Snyderman, M.C. Pike, and R.J. Lefkowitz, Proc. Natl. Acad. Sci. USA, 74, 1204 (1977). (Receptor Site on Human Leukocyte) | |
| FSLLRY-Amide (M.W. 796.98) C39H60N10O8 Selective Antagonist for Protease-Activated Receptor 2 (PAR2) Agonist FSLLRY-NH2 blocks trypsin but not SLIGRL-NH2 activation of PAR2 in receptor-expressing KNRK cells. B. Al-Ani, M. Saifeddine, S.J. | |
| FTLLRNPNDK-Amide (M.W. 1215.67) C54H89N17O15 Protease-Activated Receptor 1 (PAR1) Negative Control Peptide Control for PAR1 Agonist PAR-3925-PI B.D. Blackhart, K. Emilsson, D. Nguyen, W. Teng, A.J. Martelli, S. Nystedt, J. Sundelin,... | |
| GALP (Human, 1-60) Ala-Pro-Ala-His-Arg- Gly-Arg-Gly-Gly-Trp- Thr-Leu-Asn-Ser-Ala- Gly-Tyr-Leu-Leu-Gly- Pro-Val-Leu-His-Leu- Pro-Gln-Met-Gly-Asp- Gln-Asp-Gly-Lys-Arg- Glu-Thr-Ala-Leu-Glu- Ile-Leu-Asp-Leu-Trp- Lys-Ala-Ile-Asp-Gly- Leu-Pro-Tyr-Ser-His- Pro-Pro-Gln-Pro-Ser (M.W. 6500.3) C292H451N83O84S Ligand for Galanin Receptor 2 / Target Peptide for Feeding Regulation by... | |
| Gastric Inhibitory Polypeptide (Human) Glucose-dependent Insulinotropia Polypeptide (Human) Tyr-Ala-Glu-Gly-Thr- Phe-lle-Ser-Asp-Tyr- Ser-lle-Ala-Met-Asp- Lys-lle-His-Gln-Gln- Asp-Phe-Val-Asn-Trp- Leu-Leu-Ala-Gln-Lys- Gly-Lys-Lys-Asn-Asp- Trp-Lys-His-Asn-lle- Thr-Gln (M.W. 4983.5) C226H338N60O66S [100040-31-1] A.J. Moody, L. Thim, and I. Valverde, FEBS Lett.,... | |
| Gastrin Releasing Peptide (Human) Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: GRP (Human)-TG (TG: Bovine Thyroglobulin) Specificity: GRP (Human) 100% GRP (Porcine) 75% GRP (14-27)... | |
| Gastrin Releasing Peptide (Human) Val-Pro-Leu-Pro-Ala- Gly-Gly-Gly-Thr-Val- Leu-Thr-Lys-Met-Tyr- Pro-Arg-Gly-Asn-His- Trp-Ala-Val-Gly-His- Leu-Met-NH2 (M.W. 2859.4) C130H204N38O31S2 [93755-85-2] E.R. Spindel, W.W. Chin, J. Price, L.H. Rees, G.M. Besser, and J.F. Habener, Proc. Natl. Acad. | |
| GDGViTRIR (M.W. 986.15) C41H75N15O13 J.S. Isenberg, Y. Jia, J. Fukuyama, C.H. Switzer, D.A. Wink, and D.D. Roberts, J. Biol. Chem., 282, 15404 (2007). | |
| GHRP-2 (M.W. 818) C45H55N9O6 Growth Hormone Releasing Peptide / Food Intake Stimulator | |
| GLP-1 (Human, 7-36 Amide) (Bovine, Canine, Rat, Guinea pig) His-Ala-Glu-Gly-Thr- Phe-Thr-Ser-Asp-Val- Ser-Ser-Tyr-Leu-Glu- Gly-Gln-Ala-Ala-Lys- Glu-Phe-Ile-Ala-Trp- Leu-Val-Lys-Gly-Arg- NH2 (M.W. 3297.6) C149H226N40O45 [107444-51-9] M.D. Turton, D. OâShea, I. Gunn, S.A. Beak, C.M.B. Edwards,... | |
| GLP-1 (Human, 7-37) (Bovine, Canine, Rat, Guinea pig) His-Ala-Glu-Gly-Thr- Phe-Thr-Ser-Asp-Val- Ser-Ser-Tyr-Leu-Glu- Gly-Gln-Ala-Ala-Lys- Glu-Phe-Ile-Ala-Trp- Leu-Val-Lys-Gly-Arg- Gly (M.W. 3355.7) C151H228N40O47 G.G. Holz IV, W.M. Kühtreiber, and J.F. Habener, Nature, 361, 362 (1993). | |
| GLP-2 (Human) His-Ala-Asp-Gly-Ser- Phe-Ser-Asp-Glu-Met- Asn-Thr-Ile-Leu-Asp- Asn-Leu-Ala-Ala-Arg- Asp-Phe-Ile-Asn-Trp- Leu-Ile-Gln-Thr-Lys- Ile-Thr-Asp (M.W. 3766.1) C165H254N44O55S [223460-79-5] D.J. Drucker, Gut, 50, 4289 (2002). (Review) B. Hartmann, A.H. Johnsen, C. Ørskov, K. Adelhorst, L. Thim,... | |
| Gly-Arg-Gly-Asp-Ser (M.W. 490.47 ) C17H30N8O9 S.K. Akiyama and K.M. Yamada, J. Biol. Chem., 260, 10402 (1985). (Original) K. Olden, S. Mohla, S.A. Newton, S.L. White, and M.J. Humphries, Ann. N. | |
| Gly-His-Lys ⢠AcOH ⢠H2O (M.W. 340.38 ⢠60.05 ⢠18.02) C14H24N6O4 ⢠CH3COOH ⢠H2O [72957-37-0] L. Pickart, L. Thayer, and M.M. Thaler, Biochem. Biophys. Res. Commun., 54, 562... | |
| Gly-Trp-Thr-Leu-Asn- Ser-Ala-Gly-Tyr-Leu- Leu-Gly-Pro-His-Ala- Ile-Asp-Asn-His-Arg- Ser-Phe-Ser-Asp-Lys- His-Gly-Leu-Thr-NH2 (M.W. 3164.5) C141H211N43O41 [114547-31-8] M.E. Vrontakis, L.M. Peden, M.L. Duckworth, and H.G. Friesen, J. Biol. Chem., 262, 16755 (1987). (Original; cDNA-Pituitary Tumor) L.M. Kaplan,... | |
| Gly-Trp-Thr-Leu-Asn- Ser-Ala-Gly-Tyr-Leu- Leu-Gly-Pro-His-Ala- Val-Gly-Asn-His-Arg- Ser-Phe-Ser-Asp-Lys- Asn-Gly-Leu-Thr-Ser (M.W. 3157.4) C139H210N42O43 [119418-04-1] M. Bersani, A.H. Johnsen, P. Højrup, B.E. Dunning, J.J. Andreasen, and J.J. Holst, FEBS Lett., 283, 189 (1991). (Original) J.N. | |
| Glycyl-Glycine (M.W. 132.12) C4H8N2O3 [556-50-3] Grade AA | |
| Glycyl-Glycyl-Glycin e (M.W. 189.17) C6H11N3O4 [556-33-2] Grade AA | |
| Glycyl-Glycyl-L-Hist idine (M.W. 269.26) C10H15N5O4 [93404-95-6] Cu-Binding Peptide Show-Jy Lau, T.P.A. Kruch, and B. Sarkar, J. Biol. Chem., 249, 5878 (1974). Grade A | |
| Glycyl-L-Leucine (M.W. 188.22) C8H16N2O3 [869-19-2] Grade AA | |
| Glycyl-L-Phenylalani ne (M.W. 222.24) C11H14N2O3 [3321-03-7] Grade AA | |
| Glycyl-L-Phenylalani ne Amide (M.W. 221.26 ⢠60.05) C11H15N3O2 ⢠CH3COOH [13467-26-0] Grade AA | |
| Glycyl-L-Proline (M.W. 172.18) C7H12N2O3 [704-15-4] Grade AA | |
| Glycylglycyl-L-Tyros yl-L-Arginine (M.W. 451.48 ⢠60.05 ⢠36.03) C19H29N7O6 ⢠CH3COOH ⢠H2O Synthetic Product Affinity Ligand for Papain M.O. Funk, Y. Nakagawa, J. Skochdopole, and E.T. Kaiser, Int. J. | |
| GRADSP (M.W. 601.62) C23H39N9O10 Negative Control for Fibronectin Inhibitors D.G. Hoyt, J.M. Rusnak, R.J. Mannix, R.A. Modzelewski, C.S. Johnson, and J.S. Lazo, Cancer Res., 56, 4146 (1996). | |
| GRGDNP (M.W. 614.62) C23H38N10O10 Inhibitor of Cell Adhesion to Fibronectin M.D. Pierschbacher and E. Ruoslahti, J. Biol. Chem., 262, 17294 (1987). | |
| GRGES (M.W. 504.50) C18H32N8O9 Negative Control for PFA-4189-v C.D. Buckley, D. Pilling, N.V. Henriquez, G. Parsonage, K. Threlfall, D. S-Toellner, D.L. Simmons, A.N. Akbar, J.M. Lord, and M. Salmon, Nature,... | |
| Growth Hormone Releasing Factor (Human) Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: GRF (Human)-KLH (KLH: Keyhole Limpet Hemocyanin) Specificity: GRF (Human) 100% GRF (Porcine) 100%... | |
| Growth Hormone Releasing Factor (Human) Tyr-Ala-Asp-Ala-Ile- Phe-Thr-Asn-Ser-Tyr- Arg-Lys-Val-Leu-Gly- Gln-Leu-Ser-Ala-Arg- Lys-Leu-Leu-Gln-Asp- lle-Met-Ser-Arg-Gln- Gln-Gly-Glu-Ser-Asn- Gln-Glu-Arg-Gly-Ala- Arg-Ala-Arg-Leu-NH2 (M.W. 5039.7) C215H358N72O66S [83930-13-6] R. Guillemin, P. Brazeau, P. Böhlen, F. Esch, N. Ling, and W.B. | |
| GSWFR H-Gly-Ser-Trp-Phe-Ar g-OH (M.W. 651.73) C31H41N9O7 Growth-Hormone Secretagogue (GHS) Receptor Agonist / Stimulates Food-Intake K. Ohinata, K. Kobayashi, M. Yoshikawa, Peptides, 27, 1632 (2006). | |
| Guangxitoxin-1E GxTX-1E Tarantula, Plesiophrictus guangxiensis Trifluoroacetate Form Glu-Gly-Glu-Cys-Gly- Gly-Phe-Trp-Trp-Lys- Cys-Gly-Ser-Gly-Lys- Pro-Ala-Cys-Cys-Pro- Lys-Tyr-Val-Cys-Ser- Pro-Lys-Trp-Gly-Leu- Cys-Asn-Phe-Pro-Met- Pro (Disulfide bonds undetermined) Kv2.1/Kv2.2 Channel Blocker / Enhancer of Glucose-Stimulated Insulin Secretion J. Herrington, Y.-P. | |
| GYPGKF-Amide (M.W. 666.78) C33H46N8O7 PAR4 Tethered Ligand (Murine) / Protease-Activated Receptor 4 (PAR4) Agonist M.L. Kahn, Y.W. Zheng, W. Huang, V. Bigornia, D. Zeng, S. Moff, R. Farese, C. Tam,... | |
| GYPGQV-Amide (M.W. 618.70) C28H42N8O8 PAR4 Tethered Ligand (Human) / Protease-Activated Receptor 4 (PAR4) Agonist W. Xu, H. Andersen, T.E. Whitmore, S.R. Presnell, D.P. Yee, A. Ching, T. Gilbert, E.W. Davie,... | |
| H-Ala-Phe(4-F)-Arg-C ha-Cit-Tyr-Amide Protease-Activated Receptor 1 (PAR1) Agonist A. Kawabata, M. Saifeedine, B. A-Ani, L. Leblond, and M.D. Hollenberg, J. of Pharm. and Exper. Therap., 288, 358 (1999). | |
| H-Ala-Phe(4-F)-Arg-C ha-homoArg-Tyr-NH2 (M.W. 896.09) C43H66N13O7FThrombin Receptor Activating Peptide D.M. Feng, D.F. Veber, T.M. Connolly, C. Condra, M.J. Tang, and R.F. Nutt, J. Med. Chem.,38 4125 (1995). H.-S. Ahn, C.Foster, G. | |
| H-D-Arg-Pro-Lys-Pro- D-Phe-Gln-D-Trp-Phe- D-Trp-Leu-Leu-NH2 (M.W. 1516.87) C79H109N19O12 Ghrelin Antagonist / Potent Ghrelin Inverse Agonist Bombesin Antagonist P.J. Woll and E. Rozengurt, Proc. Natl. Acad. Sci. USA, 85, 1859 (1988). (Original: Bombesin... | |
| H-E[c(RGDyK)]2 (M.W. 1350.47) C59H87N19O18 RGD Tumor Targeting and Tumor Imaging Peptide (Requires further derivatization before use) Y. Wu, X. Zhang, Z. Xiong, Z. Cheng , D.R. Fisher, S. Liu, S.S. | |
| H-E{E[cRGDfK]2}2 (M.W. 2748.04) C123H179N39O34 Tetrameric RGD Peptide S. Liu, Z.J. He, W.Y. Hsieh, Y.S. Kim, and Y. Jiang, Bioconjugate Chem., 17, 1499 (2006). S. Liu, W.Y. Hsieh, Y. Jiang, Y.S. | |
| H-Gly-Gly-Gly-Gly-Ar g-Gly-Asp-Ser-Pro-OH GGGGRGDSP (M.W. 758.75) C28H46N12O13 | |
| H-Gly-Ser-Dap(n-Octa noyl)-Phe-Leu-NH2 Dap = 2,3-diaminopropionic acid (M.W. 633.79) C31H51N7O7 Growth-Hormone Releasing Peptide Ghrelin Analog Active Fragment M.A. Bednarek, S.D. Feighner, S.-S. Pong, K.K. McKee, D.L. Hreniuk, M.V. Silva, V.A. Warren,... | |
| H-Gly-Ser-Dap(n-Octa noyl)-Phe-Leu-Ser-Pr o-Glu-His-Gln-Lys-Al a-Gln-Gln-Arg-Lys-Gl u-Ser-Lys-Lys-Pro-Pr o-Ala-Lys-Leu-Gln-Pr o-Arg-OH Dap = 2, 3-diaminopropionic acid Growth-Hormone Releasing Peptide / Ghrelin Analog (M.W. 3313.88) C147H246N46O41 M.A. Bednarek, S.D. Feighner, S.-S. Pong, K.K. McKee, D.L. | |
| H-Gly-Ser-Ser(n-Octa noyl)-Phe-Leu-NH2 (M.W. 634.78) C31H51N6O8 M.A. Bednarek, S.D. Feighner, S.-S. Pong, K.K. McKee, D.L. Hreniuk, M.V. Silva, V.A. Warren, A.D. Howard, L.H.Y. Van der Ploeg, and J.V. Heck, J. Med. | |
| H-Gly-Ser-Ser(n-Octa noyl)-Phe-Leu-Ser-Pr o-Glu-His-Gln-Arg-Va l-Gln-Gln-Arg-Lys-Gl u-Ser-NH2 (M.W. 2225.51) C96H157N31O30 M.A. Bednarek, S.D. Feighner, S.-S. Pong, K.K. McKee, D.L. Hreniuk, M.V. Silva, V.A. Warren, A.D. Howard, L.H.Y. Van der Ploeg, and J.V. | |
| H-Gly-Ser-Ser(n-Octa noyl)-Phe-Leu-Ser-Pr o-Glu-His-Gln-Arg-Va l-Gln-Gln-OH (M.W. 1725.94) C76H121N22O24 M.A. Bednarek, S.D. Feighner, S.-S. Pong, K.K. McKee, D.L. Hreniuk, M.V. Silva, V.A. Warren, A.D. Howard, L.H.Y. Van der Ploeg, and J.V. Heck,... | |
| H-Gly-Ser-Ser(n-Octa noyl)-Phe-Leu-Ser-Pr o-Glu-His-Gln-NH2 (M.W. 1213.37) C55H84N14O17 M.A. Bednarek, S.D. Feighner, S.-S. Pong, K.K. McKee, D.L. Hreniuk, M.V. Silva, V.A. Warren, A.D. Howard, L.H.Y. Van der Ploeg, and J.V. Heck, J. | |
| H-Gly-Ser-Ser-Phe-Le u-NH2 (M.W. 508.58) C23H36N6O7 Non-acylated Analog of Ghrelin (Human, 1-5) | |
| H-Gly-Ser-Ser-Phe-Le u-Ser-Pro-Glu-His-Gl n-Arg-Val-Gln-Gln-Ar g-Lys-Glu-Ser-NH2 (M.W. 2099.31) C88H143N31O29 Non-acylated Analog of Ghrelin (Human, 1-18) | |
| H-Gly-Ser-Ser-Phe-Le u-Ser-Pro-Glu-His-Gl n-Arg-Val-Gln-Gln-OH (M.W. 1599.74) C68H106N22O23 Non-acylated Analog of Ghrelin (Human, 1-14) | |
| H-Gly-Ser-Ser-Phe-Le u-Ser-Pro-Glu-His-Gl n-NH2 (M.W. 1087.17) C47H70N14O16 Non-acylated Analog of Ghrelin (Human, 1-10) | |
| H-Lys-Leu-D-Leu-Arg- Leu-Leu-D-Lys-D-Lys- Leu-D-Leu-Arg-Leu-D- Leu-Leu-Lys-NH2 (M.W. 1860.56) C90H174N26O15 D-,L- Peptide with Antitumor Activity N. Papo, M. Shahar, L. Eisenbach, and Y. Shai, J. Biol. Chem., 278, 21018 (2003). | |
| H-Lys-Lys-Ala-Leu-Le u-Ala-Leu-Ala-Leu-Hi s-His-Leu-Ala-His-Le u-Ala-Leu-His-Leu-Al a-Leu-Ala-Leu-Lys-Ly s-Ala-OH (M.W. 2779.53) C132H228N38O27 Amphipathic Peptide Antibiotic, LAH4 A. Kichler, C. Leborgne, J. März, O. Danos, and B. Bechinger, Proc. Natl. Acad. Sci. USA, 100... | |
| H-Phe-Asn-Ala-Pro-Ph e-Asp-Val-Gly-Ile-Ly s-Leu-Ser-Gly-Ala-Gl n-Tyr-Gln-Gln-His-Gl y-Arg-Ala-Leu-NH2 FNAPFDVGIKLSGAQYQQHG RAL-NH2 (M.W. 2516.87) C114H174N34O31 Suppressor of Food Intake and Gastric Emptying J.V. Zhang, P. Ren, O. Avsian-Kretchmer, C. Luo, R. Rauch, C. Klein, and... | |
| H-Sar-Arg-Val-Tyr-Il e-His-Pro-Phe-OH Sar-RVYIHPF (M.W. 1002.19) C49H71N13O10 Vasoconstrictive Peptide / Angiotensin Peptide R.J. Kokje, W.L. Wilson, T.E. Brown, V.T. Karamyan, J.W. Wright, and R.C. Speth, Hypertension, 49, 1328 (2007). | |
| H-Ser-Ala-Leu-Leu-Ar g-Ser-Ile-Pro-Ala-Gl y-Ala-Ser-Arg-Leu-Le u-Leu-Leu-Thr-gly-Gl u-Ile-Asp-Leu-Pro-OH SALLRSIPAPAGASRLLLLT GEIDLP (M.W. 2645.16.2) C119H206N32O35 Neuroprotective Peptide in Alzheimerâs Disease Research T. chiba, M. Yamada, Y. Hashimoto, M. Sato, J. Sasabe, Y. Kita, K. Terashita,... | |
| H-Tyr-Arg-Leu-Leu-Se r-Phe-NH2 YRLLSF-Amide (M.W. 796.46) C39H60N10O8 Protease-Activated Receptor 2 (PAR2) Negative Control Peptide of PAR-3888-PI | |
| hBD-1 Asp-His-Tyr-Asn-Cys- Val-Ser-Ser-Gly-Gly- Gln-Cys-Leu-Tyr-Ser- Ala-Cys-Pro-Ile-Phe- Thr-Lys-Ile-Gln-Gly- Thr-Cys-Tyr-Arg-Gly- Lys-Ala-Lys-Cys-Cys- Lys (Disulfide bonds between Cys5-Cys34, Cys12-Cys27, and Cys17-Cys35) (M.W. 3928.5) C167H256N48O50S6 Antimicrobial Peptide K.W. Bensch, M. Raida, H-J. Mägert, P. Schulz-Knappe, and... | |
| hBD-2 Gly-Ile-Gly-Asp-Pro- Val-Thr-Cys-Leu-Lys- Ser-Gly-Ala-Ile-Cys- His-Pro-Val-Phe-Cys- Pro-Arg-Arg-Tyr-Lys- Gln-Ile-Gly-Thr-Cys- Gly-Leu-Pro-Gly-Thr- Lys-Cys-Cys-Lys-Lys- Pro (Disulfide bonds between Cys8-Cys37, Cys15-Cys28, and Cys20-Cys38) (M.W. 4328.2) C188H305N55O50S6 Antibacterial Peptide Specific for Gram-Negative Bacteria / Also Effective for... | |
| hBD-3 Gly-Ile-Ile-Asn-Thr- Leu-Gln-Lys-Tyr-Tyr- Cys-Arg-Val-Arg-Gly- Gly-Arg-Cys-Ala-Val- Leu-Ser-Cys-Leu-Pro- Lys-Glu-Glu-Gln-Ile- Gly-Lys-Cys-Ser-Thr- Arg-Gly-Arg-Lys-Cys- Cys-Arg-Arg-Lys-Lys (Disulfide bonds between Cys11-Cys40, Cys18-Cys33, and Cys23-Cys41) (M.W. 5155.1) C216H371N75O59S6 Antimicrobial Peptide / Staphylococcus aureus-Killing Factor J. Harder, J. Bartels,... | |
| hBD-4 Prepro hBD-4 (Human, 25-61) Glu-Leu-Asp-Arg-Ile- Cys-Gly-Tyr-Gly-Thr- Ala-Arg-Cys-Arg-Lys- Lys-Cys-Arg-Ser-Gln- Glu-Tyr-Arg-Ile-Gly- Arg-Cys-Pro-Asn-Thr- Tyr-Ala-Cys-Cys-Leu- Arg-Lys (Disulfide bonds between Cys6-Cys33, Cys13-Cys27, and Cys17-Cys34) (M.W. 4366.0) C180H295N63O52S6 Antimicrobial Peptide / Chemoattractant for Monocytes B.C. | |
| HD-5 (Human Defensin-5) Ala-Thr-Cys-Tyr-Cys- Arg-Thr-Gly-Arg-Cys- Ala-Thr-Arg-Glu-Ser- Leu-Ser-Gly-Val-Cys- Glu-Ile-Ser-Gly-Arg- Leu-Tyr-Arg-Leu-Cys- Cys-Arg (Disulfide bonds between Cys3-Cys31, Cys5-Cys20, and Cys10-Cys30) (M.W. 3582.1) C144H238N50O45S6 Antimicrobial Peptide in Paneth Cells T. Ganz, M.E. Selsted, D. | |
| Hepcidin / LEAP-1 (Human) Liver-Expressed Antimicrobial Peptide 1 (Human) Hepcidin-25 Asp-Thr-His-Phe-Pro- Ile-Cys-Ile-Phe-Cys- Cys-Gly-Cys-Cys-His- Arg-Ser-Lys-Cys-Gly- Met-Cys-Cys-Lys-Thr (Disulfide bonds between Cys7- Cys23, Cys10-Cys13, Cys11- Cys19, and Cys14-Cys22 [reference 5 below]) (M.W. 2789.4)... | |
| His-Ser-Gln-Gly-Thr- Phe-Thr-Ser-Asp-Tyr- Ser-Lys-Tyr-Leu-Asp- Ser-Arg-Arg-Ala-Gln- Asp-Phe-Val-Gln-Trp- Leu-Met-Asn-Thr (M.W. 3482.7) C153H225N43O49S [16941-32-5] P.J. Lefebvre and R.H. Unger (eds.), Glucagon, Pergamon Press, Oxford, 1972. (Review) | |
| HNP-1 (HNP: Human Neutrophil Peptide) Ala-Cys-Tyr-Cys-Arg- Ile-Pro-Ala-Cys-Ile- Ala-Gly-Glu-Arg-Arg- Tyr-Gly-Thr-Cys-Ile- Tyr-Gln-Gly-Arg-Leu- Trp-Ala-Phe-Cys-Cys (Disulfide bonds are formed between Cys2-Cys30, Cys4-Cys19, and Cys9-Cys29) (M.W. 3442.0) C150H222N44O38S6 Antimicrobial Peptide / Chemoattractant for Monocytes T. | |
| HNP-3 (Human Neutrophil Peptide-3) Asp-Cys-Tyr-Cys-Arg- Ile-Pro-Ala-Cys-Ile- Ala-Gly-Glu-Arg-Arg- Tyr-Gly-Thr-Cys-Ile- Tyr-Gln-Gly-Arg-Leu- Trp-Ala-Phe-Cys-Cys (Disulfide bonds between Cys2-Cys30, Cys4-Cys19, and Cys9-Cys29) (M.W. 3486.0) C151H222N44O40S6 Antimicrobial Peptide R.I. Lehrer and T. Ganz, Ann. N.Y. Acad. | |
| Hoe 140 D-Arg-Arg-Pro-Hyp-Gl y-Thi-Ser-D-Tic-Oic- Arg ⢠2AcOH ⢠4H2O (Thi: L-Thienylalanine, Tic: 1,2,3,4-Tetrahydrois oquinoline-3-Carboxy lic Acid,Oic: (3aS,7aS)-Octahydroi ndolyl-2-Carboxylic Acid) (M.W. 1304.5 ⢠120.10 ⢠72.06) C59H89N19O13S ⢠2CH3COOH ⢠H2O... | |
| Hoe 140 D-Arg-Arg-Pro-Hyp-Gl y-Thi-Ser-D-Tic-Oic- Arg (Thi: L-Thienylalanine, Tic: 1,2,3,4-Tetrahydrois oquinoline-3-Carboxy lic Acid, Oic: (3aS,7aS)-Octahydroi ndolyl-2-Carboxylic Acid) (M.W. 1304.5) C59H89N19O13S [130308-48-4] Bradykinin B2-Receptor Antagonist F.J. Hock, K. Wirth, U. Albus, W. | |
| Human, Monkey H-Phe-Asn-Ala-Pro-Ph e-Asp-Val-Gly-Ile-Ly s-Leu-Ser-Gly-Val-Gl n-Tyr-Gln-Gln-His-Se r-Gln-Ala-Leu-NH2 FNAPFDVGIKLSGVQYQQHS QAL-NH2 (M.W. 2546.89) C116H176N32O33 Suppressor of Food Intake and Gastric Emptying J.V. Zhang, P. Ren, O. Avsian-Kretchmer, C. Luo, R. Rauch, C. | |
| IAPP: Islet Amyloid Polypeptide DAP: Diabetes-Associated Peptide Lys-Cys-Asn-Thr-Ala- Thr-Cys-Ala-Thr-Gln- Arg-Leu-Ala-Asn-Phe- Leu-Val-Arg-Ser-Ser- Asn-Asn-Leu-Gly-Pro- Val-Leu-Pro-Pro-Thr- Asn-Val-Gly-Ser-Asn- Thr-Tyr-NH2 (Disulfide bond between Cys2 and Cys7) (M.W. 3920.4) C167H272N52O53S2 J.D. Leffert, C.B. Newgard, H. Okamoto,... | |
| IAPP: Islet Amyloid Polypeptide DAP: Diabetes-Associated Peptide Lys-Cys-Asn-Thr-Ala- Thr-Cys-Ala-Thr-Gln- Arg-Leu-Ala-Asn-Phe- Leu-Val-His-Ser-Ser- Asn-Asn-Phe-Gly-Ala- Ile-Leu-Ser-Ser-Thr- Asn-Val-Gly-Ser-Asn- Thr-Tyr-NH2 (Disulfide bond between Cys2 and Cys7) (M.W. 3903.3) C165H261N51O55S2 [122384-88-7] P. Westermark, C. Wernstedt, E. | |
| IbTX (Scorpion, Buthus tamulus) Pyr-Phe-Thr-Asp-Val- Asp-Cys-Ser-Val-Ser- Lys-Glu-Cys-Trp-Ser- Val-Cys-Lys-Asp-Leu- Phe-Gly-Val-Asp-Arg- Gly-Lys-Cys-Met-Gly- Lys-Lys-Cys-Arg-Cys- Tyr-Gln (Disufide bonds are formed between Cys7-Cys28, Cys13-Cys33, and Cys17-Cys35). (M.W. 4230.8) C179H274N50O55S7 [129203-60-7] Ca2+-Activated K+ Channel Blocker (Maxi-K+... | |
| Ile-Ile-Trp-Val-Asn- Thr-Pro-Glu-Gln-Thr- Ala-Pro-Tyr-Gly-Leu- Gly-Asn-Pro-Pro (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 4183.7) C188H269N45O56S4 [132699-72-0] S. Ohkubo, K.Ogi, M. Hosoya, H. Matsumoto, N. Suzuki, C. Kimura, H. Onda, and M. Fujino,... | |
| Intermedin (Human) Thr-Gln-Ala-Gln-Leu- Leu-Arg-Val-Gly-Cys- Val-Leu-Gly-Thr-Cys- Gln-Val-Gln-Asn-Leu- Ser-His-Arg-Leu-Trp- Gln-Leu-Met-Gly-Pro- Ala-Gly-Arg-Gln-Asp- Ser-Ala-Pro-Val-Asp- Pro-Ser-Ser-Pro-His- Ser-Tyr-NH2 (Disulfide bond between Cys10 and Cys15) (M.W. 5100.7) C219H349N69O66S3 Potent Cardiovascular and Renal Regulator / Suppressor for Food... | |
| Intermedin (Rat) Pro-His-Ala-Gln-Leu- Leu-Arg-Val-Gly-Cys- Val-Leu-Gly-Thr-Cys- Gln-Val-Gln-Asn-Leu- Ser-His-Arg-Leu-Trp- Gln-Leu-Val-Arg-Pro- Ser-Gly-Arg-Arg-Asp- Ser-Ala-Pro-Val-Asp- Pro-Ser-Ser-Pro-His- Ser-Tyr-NH2 (Disulfide bond between Cys10-Cys15) (M.W. 5216.9) C226H361N75O64S2 Potent Cardiovascular and Renal Regulator / Suppressor for Food Intake and... | |
| IpTXa (Scorpion, Pandinus imperator) Gly-Asp-Cys-Leu-Pro- His-Leu-Lys-Arg-Cys- Lys-Ala-Asp-Asn-Asp- Cys-Cys-Gly-Lys-Lys- Cys-Lys-Arg-Arg-Gly- Thr-Asn-Ala-Glu-Lys- Arg-Cys-Arg (Disulfide bonds between Cys3-Cys17, Cys10-Cys21, and Cys16-Cys32) (M.W. 3758.4) C148H254N58O45S6 [172451-37-5] Activator of Ca2+ Release Channels/Ryanodine Receptors H.H. Valdivia,... | |
| IRL 1620 Suc-Asp-Glu-Glu-Ala- Val-Tyr-Phe-Ala-His- Leu-Asp-Ile-Ile-Trp (Suc: Succinyl) (M.W. 1820.9) C86H117N17O27 [142569-99-1] ETB Receptor Selective Agonist M. Takai, I. Umemura, K. Yamasaki, T.Watakabe, Y. Fujitani, K. Oda, Y. Urade, T. Inui,... | |
| Kallidin (Human, Bovine) Lys-Arg-Pro-Pro-Gly- Phe-Ser-Pro-Phe-Arg ⢠3AcOH ⢠4H2O (M.W. 1188.4 ⢠180.16 ⢠72.06) C56H85N17O12 ⢠3CH3COOH ⢠4H2O [100900-38-7] J.V. Pierce and M.E. Webster, Biochem. Biophys. Res. Commun.,... | |
| Kallidin (Human, Bovine) Lys-Arg-Pro-Pro-Gly- Phe-Ser-Pro-Phe-Arg (M.W. 1188.4) C56H85N17O12 J.V. Pierce and M.E. Webster, Biochem. Biophys. Res. Commun., 5, 353 (1961). (Original; Human) D.F. Elliott and G.P. Lewis, Biochem. J., 95,... | |
| KiSS-1 Gene Product (Human, 112-121 Amide), Kisspeptin-10 Tyr-Asn-Trp-Asn-Ser- Phe-Gly-Leu-Arg-Phe- NH2 (M.W. 1302.4) C63H83N17O14 Endogenous Ligand for G-Protein Coupled Receptor hOT7T175 T. Ohtaki, Y. Shintani, S. Honda, H. Matsumoto, A. Hori,... | |
| KVPRNQDWL Human GP 100 (25â33) (M.W. 1155.33) C52H82N16O14 MHC-class I-restricted epitope in hgp100 Heteroclitic MHC class I epitope in hgp100 W.W. Overwijk, A. Tsung, K.R. Irvine, M.R. Parkhurst, T.J. Goletz,... | |
| KwFwLL (M.W. 891.14) C49H66N10O6 Potent Full Inverse Agonist for Ghrelin Receptor Holst, et al., Mol. Pharmacol., 70, 936 (2006). | |
| L-Glutamyl-L-Glutami c Acid (M.W. 276.24) C10H16N2O7 [3929-61-1] Grade A | |
| L-Histidyl-L-Leucine (M.W. 268.31) C12H20N4O3 [7763-65-7] Grade AA | |
| L-Leucyl-Glycine (M.W. 188.22 ⢠9.01) C8H16N2O3 ⢠½ H2O [686-50-0] Grade AA | |
| L-Leucyl-Glycyl-Glyc ine (M.W. 245.28) C10H19N3O4 [1187-50-4] Grade AA | |
| L-Methionyl-L-Methio nine (M.W. 280.41) C10H20N2O3S2 [7349-78-2] Grade A | |
| L-Pyroglutamyl-L-Ala nine (M.W. 200.19) C8H12N2O4 [21282-08-6] Substrate for Pyroglutamyl Peptidase R.F. Doolittle, In, Proteolytic Enzymes, Methods in Enzymology, Vol. 19, (G.E. Perlmann and L. Lorand, Eds.), Academic Press, New York,... | |
| LEAP-2 (Human) Prepro-LEAP-2 (Human, 38-77) Met-Thr-Pro-Phe-Trp- Arg-Gly-Val-Ser-Leu- Arg-Pro-Ile-Gly-Ala- Ser-Cys-Arg-Asp-Asp- Ser-Glu-Cys-Ile-Thr- Arg-Leu-Cys-Arg-Lys- Arg-Arg-Cys-Ser-Leu- Ser-Val-Ala-Gln-Glu (Disulfide bonds between Cys17-Cys28 and Cys23-Cys33) (M.W. 4581.3) C191H316N64O57S5 Antimicrobial Peptide A. Krause, R. Sillard, B. Kleemeier,... | |
| Leu-Leu-Gly-Asp-Phe- Phe-Arg-Lys-Ser-Lys- Glu-Lys-Ile-Gly-Lys- Glu-Phe-Lys-Arg-Ile- Val-Gln-Arg-Ile-Lys- Asp-Phe-Leu-Arg-Asn- Leu-Val-Pro-Arg-Thr- Glu-Ser LLGDFFRKSKEKIGKEFKRI VQRIKDFLRNLVPRTES (M.W. 4493.30) C205H340N60O53 Cathelicidin Antimicrobial Peptide 1. G.H. Gudmundsson, B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo,Eur. | |
| Leu-Pro-Phe-Phe-Asp (M.W. 637.72) C33H43N5O8 Inhibitor of Amyloid Deposition C. Soto, E.M. Sigurdsson, L. Morelli, R.A. Kumar, E.M. Castano, and B. Frangione, Nat. Med., 4, 822 (1998). (Original, Pharmacol.) | |
| Leu-Pro-Phe-Phe-Asp (M.W. 637.74) C33H43N5O8 Inhibitor of Amyloid Deposition C. Soto, E.M. Sigurdsson, L. Morelli, R.A. Kumar, E.M. Castano, and B. Frangione, Nat. Med., 4, 822 (1998). (Original) | |
| Leu-Val-Gln-Pro-Arg- Gly-Ser-Arg-Asn-Gly- Pro-Gly-Pro-Trp-Gln- Gly-Gly-Arg-Arg-Lys- Phe-Arg-Arg-Gln-Arg- Pro-Arg-Leu-Ser-His- Lys-Gly-Pro-Met-Pro- Phe (M.W. 4195.8) C184H297N69O43S [252642-12-9] Ligand for APJ Receptor K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M.-X. Zou, Y. Kawamata,... | |
| Liver-Expressed Antimicrobial Peptide 1 (Mouse) Asp-Thr-Asn-Phe-Pro- Ile-Cys-Ile-Phe-Cys- Cys-Lys-Cys-Cys-Asn- Asn-Ser-Gln-Cys-Gly- Ile-Cys-Cys-Lys-Thr (Disulfide bonds undetermined) (M.W. 2754.2) C111H169N31O35S8 Iron-Regulatory Hormone C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, P. Brissot,... | |
| LSIGKV-NH2 (M.W. 614.79) C28H54N8O7 Protease-Activated Receptor 2 (PAR2) Negative Control for PAR-3889-PI I.A. Akers, M. Parsons, M.R. Hill, M.D. Hollenberg, S. Sanjar, G.J. Laurent, and R.J. McAnulty, Am. J. Physiol. | |
| Lyophilized from Dilute HCI Solutionl Asp-Ala-Glu-Phe-Arg- His-Asp-Ser-Gly-Tyr- Glu-Val-His-His-Gln- Lys-Leu-Val-Phe-Phe- Ala-Glu-Asp-Val-Gly- Ser-Asn-Lys-Gly-Ala- Ile-Ile-Gly-Leu-Met- Val-Gly-Gly-Val-Val (M.W. 4329.89) C194H295N53O58S [131438-79-4] Specific Form Easily Transferrable to beta-Structure I. Kaneko, N. Yamada, Y. Sakuraba, M. | |
| Lys-Ala-Pro-Ser-Gly- Arg-Met-Ser-Ile-Val- Lys-Asn-Leu-Gln-Asn- Leu-Asp-Pro-Ser-His- Arg-Ile-Ser-Asp-Arg- Asp-Tyr(SO3H)-Met-Gl y-Trp-Met-Asp-Phe-NH 2 (M.W. 3945.4) C167H263N51O52S4 [96827-04-2] Y. Takahashi, K. Kato, Y. Hayashizaki, and K. Matsubara, Proc. Natl. Acad. Sci. U.S.A., 82, 1931 (1987). (Original; | |
| Lys-Ala-Pro-Ser-Gly- Arg-Val-Ser-Met-Ile- Lys-Asn-Leu-Gln-Ser- Leu-Asp-Pro-Ser-His- Arg-Ile-Ser-Asp-Arg- Asp-Tyr(SO3H)-Met-Gl y-Trp-Met-Asp-Phe-NH 2 (M.W. 3918.4) C166H262N50O52S4 V. Mutt and J.E. Jorpes, Eur. J. Biochem., 6, 156 (1968). (Original; Partial Structure) V. Mutt and J.E. Jorpes,... | |
| Lys-Arg-Pro-Hyp-Gly- Phe-Ser-Pro-Phe-Arg (M.W. 1204.4) C56H85N17O13 M. Sasaguri, M. Ikeda, M. Ideishi, and K. Arakawa, Biochem. Biophys. Res. Commun., 150, 511 (1988). (Original) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook... | |
| Lys-Lys-Lys-Asp-Lys- Val-Lys-Lys-Gly-Gly- Pro-Gly-Ser-Glu-Cys- Ala-Glu-Trp-Ala-Trp- Gly-Pro-Cys-Thr-Pro- Ser-Ser-Lys-Asp-Cys- Gly-Val-Gly-Phe-Arg- Glu-Gly-Thr-Cys-Gly- Ala-Gln-Thr-Gln-Arg- Ile-Arg-Cys-Arg-Val- Pro-Cys-Asn-Trp-Lys- Lys-Glu-Phe-Gly-Ala- Asp-Cys-Lys-Lys-Phe- Glu-Asn-Trp-Gly-Ala- Cys-Asp-Gly-Gly-Thr- Gly-Thr-Lys-Val-Arg- Gln-Gly-Tyr-Thr-Leu- Lys-Lys-Ala-Arg-Tyr- Asn-Ala-Gln-Cys-Gln- Glu-Thr-Ile-Arg-Val- Thr-Lys-Pro- Cys-Thr-Pro-Lys-Thr- Lys-Ala-Lys-Ala-Lys- Ala-Lys-Lys-Gly-Lys- Gly-Lys-Asp (Disulfide bonds between Cys15-Cys39,Cys23-Cy s48,Cys30-Cys52,Cys6... | |
| Lys-Phe-Ile-Gly-Leu- Met-NH2 ⢠2AcOH ⢠3H2O (M.W. 706.94 ⢠120.10 ⢠54.05) C34H58N8O6S ⢠2CH3COOH ⢠3H2O S. Sakakibara and M. Fujino, Bull. Chem. Soc. Japan, 39, 947 (1966). (Chem. | |
| Lys-Phe-Ile-Gly-Leu- Met-NH2 (M.W. 706.94) C34H58N8O6S S. Sakakibara and M. Fujino, Bull. Chem. Soc. Japan, 39, 947 (1966). (Chem. Synthesis) | |
| Lysyl-Des-Arg9-Brady kinin Lys-Arg-Pro-Pro-Gly- Phe-Ser-Pro-Phe ⢠2AcOH ⢠4H2O (M.W. 1032.2 ⢠120.10 ⢠72.06) C50H73N13O11 ⢠2CH3COOH ⢠4H2O Bradykinin B1-Receptor Selective Agonist J.P. Galizzi, M.C. Bodinier, B. Chapelain, S.M. | |
| Lysyl-Des-Arg9-Brady kinin Lys-Arg-Pro-Pro-Gly- Phe-Ser-Pro-Phe (M.W. 1032.2) C50H73N13O11 [71800-36-7] Bradykinin B1-Receptor Selective Agonist J.P. Galizzi, M.C. Bodinier, B. Chapelain, S.M. Ly, L. Coussy, S. Giraud, G. Neliat, and T. Jean, Br. | |
| M.W. > 8000 cut off by dialysis, NCA polymerized product [26124-78-7] | |
| M.W. > 8000 cut off by dialysis, NCA polymerized product | |
| Mast Cell Degranulating Peptide (Honeybee, Apis mellifera) Ile-Lys-Cys-Asn-Cys- Lys-Arg-His-Val-Ile- Lys-Pro-His-Ile-Cys- Arg-Lys-Ile-Cys-Gly- Lys-Asn-NH2 (Disulfide bonds between Cys3-Cys15 and Cys5-Cys19) (M.W. 2587.2) C110H192N40O24S4 [32908-73-9] Voltage-Dependent K+ Channel Blocker E. Haberman, Science, 177,... | |
| MBP (1-20) ASQKRPSQRSKYLATASTMD H-Ala-Ser-Gln-Lys-Ar g-Pro-Ser-Gln-Arg-Se r-Lys-Tyr-Leu-Ala-Th r-Ala-Ser-Thr-Met-As p-OH (M.W. 2226.51) C92H156N30O32S Immunogenic Peptide purity >95% | |
| MBP (111-129) LSRFSWGAEGQRPGFGYGG H-Leu-Ser-Arg-Phe-Se r-Trp-Gly-Ala-Glu-Gl y-Gln-Arg-Pro-Gly-Ph e-Gly-Tyr-Gly-Gly-OH (M.W. 2029.22) C92H129N27O26 Immunogenic Peptide | |
| MBP (87-99) VHFFKNIVTPRTP H-Val-His-Phe-Phe-Ly s-Asn-Ile-Val-Thr-Pr o-Arg-Thr-Pro-OH (M.W. 1555.86) C74H114N20O17 Immunogenic Peptide | |
| MCH (Human) (Rat, Mouse) Asp-Phe-Asp-Met-Leu- Arg-Cys-Met-Leu-Gly- Arg-Val-Tyr-Arg-Pro- Cys-Trp-Gln-Val (Disulfide bond between Cys7-Cys16) (M.W. 2386.8) C105H160N30O26S4 [128315-56-0] Appetite Boosting Peptide K.M. Knigge, D. Baxter-Grillo, J. Speciale, and J. Wagner, Peptides, 17,... | |
| Melanocortin 1, 3, 4 and 5 Receptor Agonist M. Cai, A.V. Mayorov, C. Cabello, KM. Stankova, D. Trivedi, and V.J. Hruby, J. Med. Chem., 48, 1839 (2005). | |
| Melanocortin 4 Receptor Antagonist M.A. Bednarek, T. MacNeil, R.N. Kalyani, R. Tang, L.H.Y. Van der Ploeg, and D.H. Weinberg, J. Med. Chem., 44, 3665 (2001). | |
| Melanotan II, MT-II Potent Melanocortin 1, 3, 4 and 5 Receptor Agonist F. Al-Obeidi,V.J. Hruby, A.M. Castrucci, and M.E. Hadley, J. Med. Chem., 32,174 (1989). | |
| Met-Lys-Arg-Pro-Pro- Gly-Phe-Ser-Pro-Phe- Arg (M.W. 1319.6) C61H94N18O13S [550-19-6] D.F. Elliott and G.P. Lewis, Biochem. J., 95, 437 (1965). (Original; Bovine) I. Ohkubo, K. Kurachi, T. Takasawa, H. Shiokawa, and M. Sasaki,... | |
| Molluscan Cardioexcitatory Neuropeptide Phe-Met-Arg-Phe-NH2 ⢠1½ AcOH ⢠2H2O (M.W. 598.76 ⢠90.08 ⢠36.03) C29H42N8O4S ⢠11/2CH3COOH ⢠2H2O D.A. Price and M.J. Greenberg, Science, 197, 670 (1977). (Original)... | |
| Molluscan Cardioexcitatory Neuropeptide Phe-Met-Arg-Phe-NH2 (M.W. 598.76) C H N O S [64190-70-1] D.A. Price and M.J. Greenberg, Science, 197, 670 (1977). (Original) * The biological activity of these peptides is... | |
| MTX1, MT1 (Green Mamba, Dendroaspis angusticeps) Leu-Thr-Cys-Val-Thr- Ser-Lys-Ser-Ile-Phe- Gly-Ile-Thr-Thr-Glu- Asn-Cys-Pro-Asp-Gly- Gln-Asn-Leu-Cys-Phe- Lys-Lys-Trp-Tyr-Tyr- Ile-Val-Pro-Arg-Tyr- Ser-Asp-Ile-Thr-Trp- Gly-Cys-Ala-Ala-Thr- Cys-Pro-Lys-Pro-Thr- Asn-Val-Arg-Glu-Thr- Ile-Arg-Cys-Cys-Glu- Thr-Asp-Lys-Cys-Asn- Glu (Disulfide bonds between Cys3-Cys24, Cys17-Cys42, Cys46-Cys58, and Cys59-Cys64) (M.W. 7509.5)... | |
| MTX7, MT7, m1-toxin 1 (Green Mamba, Dendroaspis angusticeps) Leu-Thr-Cys-Val-Lys- Ser-Asn-Ser-Ile-Trp- Phe-Pro-Thr-Ser-Glu- Asp-Cys-Pro-Asp-Gly- Gln-Asn-Leu-Cys-Phe- Lys-Arg-Trp-Gln-Tyr- Ile-Ser-Pro-Arg-Met- Tyr-Asp-Phe-Thr-Arg- Gly-Cys-Ala-Ala-Thr- Cys-Pro-Lys-Ala-Glu- Tyr-Arg-Asp-Val-Ile- Asn-Cys-Cys-Gly-Thr- Asp-Lys-Cys-Asn-Lys (Disulfide bonds between Cys3-Cys24, Cys17-Cys42, Cys46-Cys57, and Cys58-Cys63) (M.W. | |
| Myelin Oligodendrocyte Protein (35-55) H-Met-Glu-Val-Gly-Tr p-Tyr-Arg-Ser-Pro-Ph e-Ser-Arg-Val-Val-Hi s-Leu-Tyr-Arg-Asn-Gl y-Lys-OH (M.W. 2582.01) C118H177N35O29S Encephalitogenic Determinant M Ichikawa, T.G. Johns, J. Liu, and C.C. Bernard, J. Immunol. 157, 919-926 (1996). H.-C. von... | |
| Myelin Oligodendrocyte Protein (40-54) YRSPFSRVVHLYRNG H-Tyr-Arg-Ser-Pro-Ph e-Ser-Arg-Val-Val-Hi s-Leu-Tyr-Arg-Asn-Gl y-OH (M.W. 1851.12) C84H127N27O21 Sun, D. et al. Int. Immunol., 15, 261(2003). | |
| Myelin Oligodendrocyte Protein (92-106) DEGGYTCFFRDHSYQ H-Asp-Glu-Gly-Gly-Ty r-Thr-Cys-Phe-Phe-Ar g-Asp-His-Ser-Tyr-Gl n-OH (M.W. 1823.91) C80H104N21O27S Immunogenic Peptide PURITY > 95% | |
| Myelin Proteolipid Protein (139-151) H-His-Ser-Leu-Gly-Ly s-Trp-Leu-Gly-His-Pr o-Asp-Lys-Phe-OH (M.W. 1521.76) C72H104N20O17 Encephalitogenic Determinant V.K. Kuchroo, J.M. Greer, D. Kaul, G. Ishioka, A. Franco, A. Sette, R.A. Sobel, and M.A. Lees, J. | |
| Myelin Proteolipid Protein (178-191) NTWTTCQSIAFPSK H-Asn-Thr-Trp-Thr-Th r-Cys-Gln-Ser-Ile-Al a-Phe-Pro-Ser-Lys-OH (M.W. 1582.79) C70H105N18O22S Immunogenic Peptide | |
| Myelin Proteolipid Protein (180-199) WTTCQSIAFPSKTSASIGSL H-Trp-Thr-Thr-Cys-Gl n-Ser-Ile-Ala-Phe-Pr o-Ser-Lys-Thr-Ser-Al a-Ser-Ile-Gly-Ser-Le u-OH (M.W. 2084.37) C92H144N23O30S Immunogenic Peptide | |
| Myelin Proteolipid Protein (57-70) YEYLINVIHAFQYV H-Tyr-Glu-Tyr-Leu-Il e-Asn-Val-Ile-His-Al a-Phe-Gln-Tyr-Val-OH (M.W. 1772.05) C87H122N18O22 Immunogenic Peptide | |
| N-Ac-Muramyl-Ala-D-G lu-NH2 ⢠2H2O (Mur: Muramic acid) (M.W. 492.48 ⢠36.03 ) C19H32N4O11 ⢠2H2O [53678-77-6] Muramyl Dipeptide F. Ellouz, A. Adam, R. Ciorbaru, and E. Lederer, Biochem. Biophys. Res. | |
| N-Ac-Muramyl-Ala-D-G lu-NH2 (Mur: Muramic acid) (M.W. 492.48) C19H32N4O11 [53678-77-6] F. Ellouz, A. Adam, R. Ciorbaru, and E. Lederer, Biochem. Biophys. Res. Commun., 59, 1317 (1974). (Original) S. Kotani, Y. Watanabe,... | |
| N-Me-Asp-Arg-Val-Tyr -Ile-His-Pro-Phe-OH (M.W. 1060.23) C51H73N13O12 Vasoconstrictive Peptide / Angiotensin Peptide R.J. Kokje, W.L. Wilson, T.E. Brown, V.T. Karamyan, J.W. Wright, and R.C. Speth, Hypertension, 49, 1328 (2007). | |
| Neuropeptide Y (Human) Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: NPY (Human)-TG (TG: BovineThyroglobulin) NPY (Human) 100% Specificity: NPY (Porcine) 100% NPY (Human, 1-9) <0.1%... | |
| Nic-Tyr-Lys(Z-Arg)-H is-Pro-Ile (Nic-Nicotinoyl, Z-: Carbobenzoxy) (M.W. 1052.2) C52H69N13O11 [127060-75-7] Angiotensin AT2 Receptor Agonist S.E. Whitebread, V. Taylor, S.P. Bottari, B. Kamber, and M. de Gasparo, Biochem. Biophys. Res. Commun., 181,... | |
| Non-Acylated Ghrelin (Human) H-Gly-Ser-Ser-Phe-Le u-Ser-Pro-Glu-His-Gl n-Arg-Val-Gln-Gln-Ar g-Lys-Glu-Ser-Lys-Ly s-Pro-Pro-Ala-Lys-Le u-Gln-Pro-Arg-OH (M.W. 3244.74) C141H235N47O41 Counteracts Metabolic Effects of Acylated Ghrelin F. Broglio, et al., J. Clin. Endoc. and Metabolism, 89, 3062 (2004). | |
| Non-Acylated Ghrelin (Rat) H-Gly-Ser-Ser-Phe-Le u-Ser-Pro-Glu-His-Gl n-Lys-Ala-Gln-Gln-Ar g-Lys-Glu-Ser-Lys-Ly s-Pro-Pro-Ala-Lys-Le u-Gln-Pro-Arg-OH (M.W. 3188.67) C139H231N45O41 Counteracts Metabolic Effects of Acylated Ghrelin H Hosoda, M Kojima, H Matsuo, and K Kangawa, Biochem. Biophys. Res. | |
| Obestatin (Human) PGH-4429-s Phe-Asn-Ala-Pro-Phe- Asp-Val-Gly-Ile-Lys- Leu-Ser-Gly-Val-Gln- Tyr-Gln-Gln-His-Ser- Gln-Ala-Leu-NH2 (M.W. 2546.8) C116H176N32O33 Food Intake Suppressor / Ligand for GPR39 J.V. Zhang, P.-G. Ren, O. Avsian-Kretchmer, C.-W. Luo, R. Rauch, C. Klein,... | |
| Obestatin (Human, 11-23) H-Leu-Ser-Gly-Val-Gl n-Tyr-Gln-Gln-His-Se r-Gln-Ala-Leu-NH2 H-LSGVQYQQHSQAL-NH2 (M.W. 1457.62) C63H100N20O20 Truncated Analog of Obestatin J.V. Zhang, P. Ren, O. Avsian-Kretchmer, C. Luo, R. Rauch, C. Klein, and A.J.W. Hsueh, Science,... | |
| Obestatin (Rat, Mouse, 11-23) H-Leu-Ser-Gly-Ala-Gl n-Tyr-Gln-Gln-His-Gl y-Arg-Ala-Leu-NH2 H-LSGAQYQQHGRAL-NH2 (M.W. 1427.60) C61H98N22O18 Truncated Analog of Obestatin J.V. Zhang, P. Ren, O. Avsian-Kretchmer, C. Luo, R. Rauch, C. Klein, and A.J.W. Hsueh,... | |
| omega-Aga-IVA (Funnel Web Spider, Agelenopsis aperta) Lys-Lys-Lys-Cys-Ile- Ala-Lys-Asp-Tyr-Gly- Arg-Cys-Lys-Trp-Gly- Gly-Thr-Pro-Cys-Cys- Arg-Gly-Arg-Gly-Cys- Ile-Cys-Ser-Ile-Met- Gly-Thr-Asn-Cys-Glu- Cys-Lys-Pro-Arg-Leu- Ile-Met-Glu-Gly-Leu- Gly-Leu-Ala (Disulfide bonds between Cys4-Cys20, Cys12-Cys25, Cys19-Cys36 and Cys27-Cys34) (M.W. 5202.2) C217H360N68O60S10 P-type Ca2+ Channel... | |
| omega-Aga-TK, omega-Aga-IVB (Funnel Web Spider, Agelenopsis aperta) Glu-Asp-Asn-Cys-Ile- Ala-Glu-Asp-Tyr-Gly- Lys-Cys-Thr-Trp-Gly- Gly-Thr-Lys-Cys-Cys- Arg-Gly-Arg-Pro-Cys- Arg-Cys-Ser-Met-Ile- Gly-Thr-Asn-Cys-Glu- Cys-Thr-Pro-Arg-Leu- Ile-Met-Glu-Gly-Leu- D-Ser-Phe-Ala (Disulfide bonds between Cys4-Cys20, Cys12-Cys25,Cys19-Cy s36 and Cys27-Cys34) (M.W. 5273.0) C215H337N65O70S10 [145017-83-0] P-type... | |
| Peptide with Reversed Sequence of Amyloid b-Protein (Human, 1-42) (Trifluoroacetate Form) Ala-Ile-Val-Val-Gly- Gly-Val-Met-Leu-Gly- Ile-Ile-Ala-Gly-Lys- Asn-Ser-Gly-Val-Asp- Glu-Ala-Phe-Phe-Val- Leu-Lys-Gln-His-His- Val-Glu-Tyr-Gly-Ser- Asp-His-Arg-Phe-Glu- Ala-Asp (M.W. 4514.0) C203H311N55O60S [317366-82-8] Control Peptide for Amyloid beta-Protein (Human,... | |
| Peptide with Reversed Sequence of Amyloid beta-Protein (Human, 1-40) (Trifluoroacetate Form) Val-Val-Gly-Gly-Val- Met-Leu-Gly-Ile-Ile- Ala-Gly-Lys-Asn-Ser- Gly-Val-Asp-Glu-Ala- Phe-Phe-Val-Leu-Lys- Gln-His-His-Val-Glu- Tyr-Gly-Ser-Asp-His- Arg-Phe-Glu-Ala-Asp (M.W. 4329.8) C194H295N53O58S [144409-99-4] Control Peptide for Amyloid beta-Protein (Human, 1-40)... | |
| Phe-Asn-Ala-Pro-Phe- Asp-Val-Gly-Ile-Lys- Leu-Ser-Gly-Ala-Gln- Tyr-Gln-Gln-His-Gly- Arg-Ala-Leu-NH2 (M.W. 2516.8) C114H174N34O31 Food Intake Suppressor / Ligand for GPR39 J.V. Zhang, P.-G. Ren, O. Avsian-Kretchmer, C.-W. Luo, R. Rauch, C. Klein, and A.J.W. Hsueh,... | |
| Phe-Val-Pro-Ile-Phe- Thr-Tyr-Gly-Glu-Leu- Gln-Arg-Met-Gln-Glu- Lys-Glu-Arg-Asn-Lys- Gly-Gln (M.W. 2699.0) C120H188N34O35S [52906-92-0] J.C. Brown, M.A. Cook, and J.R. Dryburgh, Can. J. Biochem., 51, 533 (1973). (Original; Porcine) H. Schubert and J.C. Brown, Can. | |
| Pro-Asn-Thr-Cys-Glu- Ile-Cys-Ala-Tyr-Ala- Ala-Cys-Thr-Gly-Cys (Disulfide bonds between Cys4-Cys12 and Cys7-Cys15) (M.W. 1515.7) C60H90N16O22S4 Guanylate Cyclase C Activator M.G. Currie, K.F. Fok, J. Kato, R.J. Moore, F.K. Hamra, K.L. Duffin, and C.E. | |
| Pro-Gly-Thr-Cys-Glu- Ile-Cys-Ala-Tyr-Ala- Ala-Cys-Thr-Gly-Cys (Disulfide bonds between Cys4-Cys12 and Cys7-Cys15) (M.W. 1458.7) C58H87N15O21S4 Guanylate Cyclase C Activator R.C. Wiegand, J. Kato, M.D. Huang, K.F. Foc, J.F. Kachur, and M.G. Currie, FEBS... | |
| Proadrenomedullin N-terminal 20 Peptide (Human) Ala-Arg-Leu-Asp-Val- Ala-Ser-Glu-Phe-Arg- Lys-Lys-Trp-Asn-Lys- Trp-Ala-Leu-Ser-Arg- NH2 (M.W. 2460.8) C112H178N36O27 [150238-87-2] Hypotensive Peptide K. Kitamura, J. Sakata, K. Kangawa, M. Kojima, H. Matsuo, and T. Eto, Biochem. | |
| Proadrenomedullin N-terminal 20 Peptide (Human, 9-20) Phe-Arg-Lys-Lys-Trp- Asn-Lys-Trp-Ala-Leu- Ser-Arg-NH2 (M.W. 1618.9) C77H119N25O14 Hypotensive Peptide / Major Endogenous Form of PAMP K. Kuwasato, K. Kitamura, Y. Ishiyama, H. Washimine, J. Kato,... | |
| Proadrenomedullin N-terminal 20 Peptide (Rat) Ala-Arg-Leu-Asp-Thr- Ser-Ser-Gln-Phe-Arg- Lys-Lys-Trp-Asn-Lys- Trp-Ala-Leu-Ser-Arg- NH2 (M.W. 2477.8) C111H177N37O28 Hypotensive Peptide J. Sakata, T. Shimokubo, K. Kitamura, S. Nakamura, K. Kangawa, H. Matsuo, and T. Eto,... | |
| Pyr-Arg-Pro-Arg-Leu- Ser-His-Lys-Gly-Pro- Met-Pro-Phe (M.W. 1533.8) C69H108N22O16S [217082-60-5] Ligand for APJ Receptor K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M.-X. Zou, Y. Kawamata, S. Fukusumi, S. Hinuma, C. | |
| RGDSK (M.W. 561.60) C21H39N9O9 RGD Tumor Targeting Peptide S. Jasseron, C. Contino-Pepin, J.C. Maurizis, M. Rapp, B. Pucci, Bioorganic & Medicinal Chemistry Letters, 12, 7, (2002). S. Jasseron, C. Contino-Pepin,... | |
| RLLFT-Amide (M.W. 647.82) C31H53N9O6 Protease-Activated Receptor 1 (PAR1) Negative Control Peptide S. Asfaha, V. Brusse, K. Chapman, D.W. Zochodne, and N. Vergnolle, Br. J. Pharmacol., 135, 1101 (2002). M. Fang,... | |
| Salusin-Beta (Human) Specific Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: Salusin-Beta (Human)-TG (TG: Bovine Thyroglobulin) Specificity: Salusin-Beta (Human) + Salusin-alpha (Human) - Our undiluted antisera... | |
| Sar-Arg-Val-Tyr-Ile- His-Pro-Ala ⢠AcOH ⢠4H2O (M.W. 926.07 ⢠60.05 ⢠72.06) C43H67 N13O10 ⢠CH3COOH ⢠4H2O Angiotensin II Selective Antagonist D.T. Pals, F.D. Masucci, G.S. Denning, Jr., F. | |
| Sar-Arg-Val-Tyr-Ile- His-Pro-Ala (M.W. 926.07) C43H67N13O10 [38027-95-11] D.T. Pals, F.D. Masucci, G.S. Denning, Jr., F. Sipos, and D.C. Fessler, Circ. Res., 29, 673 (1971). (Original) F.M. Bumpus, S. Sen, R.R. Smeby,... | |
| Sar-Arg-Val-Tyr-Ile- His-Pro-Ile ⢠AcOH ⢠4H2O (M.W. 968.15 ⢠60.05 ⢠72.06) C46H73N13O10 ⢠CH3COOH ⢠4H2O Angiotensin II Selective Antagonist F.M. Bumpus, S. Sen, R.R. Smeby, C. Sweet, C.M. | |
| Sar-Arg-Val-Tyr-Ile- His-Pro-Ile (M.W. 968.15) C46H73N13O10 [37827-06-8] Angiotensin II Selective Antagonist F.M. Bumpus, S. Sen, R.R. Smeby, C. Sweet, C.M. Ferrario, and M.C. Khosla, Circ. Res., 32 and 33 (Suppl. I),... | |
| Sar-Arg-Val-Tyr-Ile- His-Pro-Thr ⢠2AcOH ⢠4H2O (M.W. 956.101 ⢠120.10 ⢠72.06) C44H69N13O11 ⢠2CH3COOH ⢠4H2O M.C. Khosla, M.M. Hall, R.B. Smeby, and F.M. Bumpus, J. Med. Chem., 17,... | |
| Sar-Arg-Val-Tyr-Ile- His-Pro-Thr (M.W. 956.10) C44H69N13O11 [53632-49-8] M.C. Khosla, M.M. Hall, R.B. Smeby, and F.M. Bumpus, J. Med. Chem., 17, 1156 (1974). (Original; Chem. Synthesis)Angiotensi n II Selective Antagonist I.H. Page... | |
| Sar-Arg-Val-Tyr-Val- His-Pro-Ala ⢠AcOH ⢠4H2O (M.W. 912.05 ⢠60.05 ⢠72.06) C42H65N13O10 ⢠CH3COOH ⢠4H2O Angiotensin II Selective Antagonist D.T. Pals, F.D. Masucci, G.S. Denning, Jr., F. Sipos,... | |
| Sar-Arg-Val-Tyr-Val- His-Pro-Ala (M.W. 912.05) C42H65N13O10 [34273-10-4] Angiotensin II Selective Antagonist D.T. Pals, F.D. Masucci, G.S. Denning, Jr., F. Sipos, and D.C. Fessler, Circ. Res., 29, 673 (1971). (Original)I.H. Page and... | |
| SFLLcit Protease-Activated Receptor 1 (PAR1 ) Agonist T. Sabo, et al., Biochem. Biophys. Res. Commun., 188, 604 (1992). | |
| SFLLR Acid Form of PAR-3942-PI H.-S. Ahn, C.Foster, G. Boykow, L. Arik, A. S.-Torhan, D. Hesk, and M. Chatterjee, Mol. Pharmacol., 51, 350 (1997). MD. Hollenberg, S.G. Yang, A.A. Laniyonu,... | |
| SFLLR-Amide Protease-Activated Receptor 1 (PAR1 ) Agonist MD. Hollenberg, S.G. Yang, A.A. Laniyonu, C.J. Moore, and M. Saifeddine, Mol. Pharmacol., 42, 186 (1992). | |
| SFLLRN Acid Form of PAR-3676-PI H.-S. Ahn, C.Foster, G. Boykow, L. Arik, A. S.-Torhan, D. Hesk, and M. Chatterjee, Mol. Pharmacol., 51, 350 (1997). R.R. Vassallo, Jr, T. Kieber-Emmons, K. | |
| SFLLRN-Amide (M.W. 747.90) C34H57N11O8 Selective Protease-Activated Receptor 1 (PAR1) Agonist R.R. Vassallo, Jr., T. Kieber-Emmons, K. Cichowski, and L.F. Brass, J. Biol. Chem., 267, 6081 (1992). N. Vergnolle, Br. J. | |
| SFLLRNP Protease-Activated Receptor 1 (PAR1 ) Agonist Acid Form M.L. Webb, D.S. Taylor, and C.J. Molloy, Biochem. Pharmacol., 45, 1577 (1993). | |
| SFLLRNPNDKYEPF (M.W. 1739.96) C81H118N20O23 Acid Form of PAR-3935-PI H.-S. Ahn, C. Foster, G. Boykow, L. Arik, A.S.-Torhan, D. Hesk, and M. Chatterjee, Mol. Pharmacol., 51, 350 (1997). J.R. Ngaiza and... | |
| SFLLRNPNDKYEPF-Amide Protease-Activated Receptor 1 (PAR1 ) Agonist J.R. Ngaiza and E.A. Jaffe, Biochem. Biophys. Res. Commun., 179, 1656 (1991). D.M. Feng, D.F. Veber, T.M. Connolly, C. Condra, M.J. Tang, and... | |
| SFNGGP-Amide (M.W. 576.61) C25H36N8O8 PAR3 Tethered Ligand (Murine) / Activates PAR1 and PAR2 K.K. Hansen, M. Saifeddine, and M.D. Hollenberg, Immunology, 112, 183 (2004). N. Vergnolle, Br. J. Pharmacol., 141,... | |
| SLIGKV (M.W. 614.79) C28H54N8O7 Acid Form of PAR-3889-PI S.K. Bohm, W. Kong, D. Bromme, S.P. Smeekens, D.C. Anderson, A. Connolly, M. Kahn, H.A. Nelken, S.R. Coughlin, D.G. Payan, and N.W. | |
| SLIGKV-Amide (M.W. 614.79) C25H54N8O7 PAR2 Tethered Ligand (Human) / Protease-Activated Receptor 2 (PAR2) Agonist S.K. Bohm, W. Kong, D. Bromme, S.P. Smeekens, D.C. Anderson, A. Connolly, M. Kahn, H.A. Nelken,... | |
| SLIGRL (M.W. 657.82 )C29H55N9O8 Acid form of PAR-3664-PI A. Bhattacharya, G.F. Smith, and M.L. Cohen, J. Pharmacol. Exp. Ther., 297, 573 (2001). B. Al-Ani, M. Saifeddine, and M.D. Hollenberg, Can. | |
| SLIGRL-Amide (M.W. 656.83) C29H56N10O7 Protease-Activated Receptor 2 (PAR2) Agonist B. Al-Ani, M. Saifeddine, and M.D. Hollenberg, Can. J. of Physiol. Pharmacol., 73, 1203 (1995). N. Vergnolle, Br. J. Pharmacol., 141,... | |
| Sodium Potassium ATPase Inhibitor-1 (Porcine) Antiserum (Na+,K+-ATPase Inhibitor-1 Antiserum) (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: SPAI-1 (Porcine, 1-49)-BSA (BSA: Bovine Serum Albumin) Specificity: SPAI-1 (Porcine,... | |
| T-Kinin (Rat) Ile-Ser-Arg-Pro-Pro- Gly-Phe-Ser-Pro-Phe- Arg ⢠2AcOH ⢠5H2O (M.W. 1260.4 ⢠120.10 ⢠90.08) C59H89N17O14 ⢠2CH3COOH ⢠5H2O H. Okamoto and L.M. Greenbaum, Biochem. Biophys. Res. Commun., 112,... | |
| T-Kinin (Rat) Ile-Ser-Arg-Pro-Pro- Gly-Phe-Ser-Pro-Phe- Arg (M.W. 1260.4) C59H89N17O14 [86030-63-9] H. Okamoto and L.M. Greenbaum, Biochem. Biophys. Res. Commun., 112, 701 (1983). (Original) E.G. Erdös (ed.) Bradykinin, Kallidin and Kallikrein, Handbook... | |
| TFLLR-Amide (M.W. 647.82) C31H53N9O6 Protease-Activated Receptor 1 (PAR1) Agonist M.D. Hollenberg, M. Saifeddine, B. al-Ani, and A. Kawabata, Can. J. Physiol. Pharmacol., 75, 832 (1997). N. Vergnolle, Br. J. Pharmacol.,... | |
| TFLLRNPNDK-Amide (M.W. 1215.67) C54H89N17O15 Protease-Activated Receptor 1 (PAR1) Agonist B.D. Blackhart, K. Emilsson, D. Nguyen, W. Teng, A.J. Martelli, S. Nystedt, J. Sundelin, and R.M. Scarborough, J. Biol. Chem., 271,... | |
| TFRGAP-Amide (M.W. 646.45) C29H46N10O7 PAR3 Tethered Ligand (Human) / Activates PAR1 and PAR2 K.K. Hansen, M. Saifeddine, and M.D. Hollenberg, Immunology, 112, 183 (2004). N. Vergnolle, Br. J. Pharmacol., 141,... | |
| The following antisera are manufactured by Yanaihara Institute, Inc. | |
| Thr-Val-Gln-Lys-Leu- Ala-His-Gln-Ile-Tyr- Gln-Phe-Thr-Asp-Lys- Asp-Lys-Asp-Asn-Val- Ala-Pro-Arg-Ser-Lys- Ile-Ser-Pro-Gln-Gly- Tyr-NH2 (M.W. 3576.0) C159H252N46O48 [159899-65-7] Adrenomedullin Antagonist S. Eguchi, Y. Hirata, H. Iwasaki, K. Sato, T.X. Watanabe, T. Inui, K. Nakajima, S. Sakakibara, and... | |
| trans-Cinnamoyl-YPGK F-Amide (M.W. 739.88) C40H49N7O7 Selective Protease-Activated Receptor 4 (PAR4) Antagonist M.D. Hollenberg, and J.L. Wallace, Br. J. Pharmacol., 134, 701 (2001). M.D. Hollenberg and M. Saifeddine, Can. J. Physiol. | |
| Trp-Ala-Gly-Gly-Asp- Ala-Ser-Gly-Glu ⢠4H2O (M.W. 848.81 ⢠72.06) C35H48N10O15 ⢠4H2O [62568-57-4] G.A. Schoenenberger and M. Monnier, Proc. Natl. Acad. Sci., USA., 74, 1282 (1977). (Original) M. Monnier, L. Dudler,... | |
| Tyr(SO3H)-Gly-Gly-Ph e-Leu (M.W. 635.69) C28H37N5O10S C.D. Unsworth and J. Hughes, Nature, 295, 519 (1982). (Original) | |
| Tyr-Arg-Gln-Ser-Met- Asn-Asn-Phe-Gln-Gly- Leu-Arg-Ser-Phe-Gly- Cys-Arg-Phe-Gly-Thr- Cys-Thr-Val-Gln-Lys (Disulfide bond between Cys16-Cys21) (M.W. 2927.3) C125H192N40O36S3 Vasopressor Fragment of Human Adrenomedullin T.X. Watanabe, Y. Itahara, T. Inui, K. Yoshizawa-Kumagaye, K. Nakajima, and S. Sakakibara,... | |
| Tyr-Arg-Gln-Ser-Met- Asn-Asn-Phe-Gln-Gly- Leu-Arg-Ser-Phe-Gly- Cys-Arg-Phe-Gly-Thr- Cys-Thr-Val-Gln-Lys- Leu-Ala-His-Gln-Ile- Tyr-Gln-Phe-Thr-Asp- Lys-Asp-Lys-Asp-Asn- Val-Ala-Pro-Arg-Ser- Lys-lle-Ser-Pro-Gln- Gly-Tyr-NH2 (Disulfide bond between Cys16-Cys21) (M.W. 6028.7) C264H406N80O77S3 Hypotensive Peptide K. Kitamura, K. Kangawa, M. Kawamoto, Y. Ichiki, S. Nakamura,... | |
| Tyr-Arg-Pro-Pro-Gly- Phe-Ser-Pro-Phe-Arg (M.W. 1223.4) C59H82N16O13 [33289-76-8] For Radioimmunoassay R.E. Lewis, S.R. Childers, and M.I. Phillips, Brain Res., 346, 263 (1985). (Radioimmunoassay) M.J. Fredrick, F.C. Abel, W.A. Rightsel, E.E. Muirhead, and... | |
| Tyr-D-Ala-Gly-Phe-D- Leu ⢠AcOH ⢠H2O (M.W. 569.65 ⢠60.05 ⢠18.02) C29H39N5O7 ⢠CH3COOH ⢠H2O [94825-57-7] E.T. Wei, L.F. Tseng, H.H. Loh, and C.H. Li, Life Sci., 21,... | |
| Tyr-D-Ala-Gly-Phe-D- Leu (M.W. 569.65) C29H39N5O7 [63631-40-3] E.T. Wei, L.F. Tseng, H.H. Loh, and C.H. Li, Life Sci., 21, 321 (1977). (Original) | |
| Tyr-D-Ala-Gly-Phe-Me t ⢠AcOH ⢠H2O (M.W. 587.69 ⢠60.05 ⢠18.02 ) C28H37N5O7S ⢠CH3COOH ⢠H2O [100929-62-6] D.H. Coy, A.J. Kastin, A.V. Schally, O. Morin, N.G. Caron, F. | |
| Tyr-D-Ala-Gly-Phe-Me t (M.W. 587.69 ) C28H37N5O7S D.H. Coy, A.J. Kastin, A.V. Schally, O. Morin, N.G. Caron, F. Labrie, J.M. Walker, R. Fertel, G.G. Berntson, and C.A. Sandman, Biochem. Biophys. Res. | |
| Tyr-D-Ala-Gly-Phe-Me t-NH2 ⢠AcOH ⢠H2O (M.W. 586.70 ⢠60.05 ⢠18.02) C28H38N6O6S ⢠CH3COOH ⢠H2O [100929-50-8] D.H. Coy, A.J. Kastin, A.V. Schally, O. Morin, N.G. Caron, F. Labrie,... | |
| Tyr-D-Ala-Gly-Phe-Me t-NH2 (M.W. 586.70) C28H38N6O6S [61090-95-7] D.H. Coy, A.J. Kastin, A.V. Schally, O. Morin, N.G. Caron, F. Labrie, J.M. Walker, R. Fertel, G.G. Berntson, and C.A. Sandman, Biochem. Biophys. Res. | |
| Tyr-Gly-Gly-Phe-Leu- Arg-Lys-Tyr-Pro (M.W. 1100.3) C54H77N13O12 [77739-21-0] N. Minamino, K. Kangawa, N. Chino, S. Sakakibara, and H. Matsuo, Biochem. Biophys. Res. Commun., 99, 864 (1981). (Original) | |
| Tyr-Gly-Gly-Phe-Leu- Arg-Lys-Tyr-Pro-Lys (M.W. 1228.4) C60H89N15O13 K. Kangawa, N. Minamino, N. Chino, S. Sakakibara, and H. Matsuo, Biochem. Biophys. Res. Commun., 99, 871 (1981). (Original) | |
| Tyr-lle-Gly-Ser-Arg- NH2 ⢠2AcOH ⢠2H2O (M.W. 593.68 ⢠120.10 ⢠36.03) C26H43N9O7 ⢠2CH3COOH ⢠2H2O Y. Iwamoto, F.A. Robey, J. Graf, M. Sasaki, H.K. Kleinman, Y. Yamada, and... | |
| Tyr-lle-Gly-Ser-Arg- NH2 (M.W. 593.68) C26H43N9O7 Y. Iwamoto, F.A. Robey, J. Graf, M. Sasaki, H.K. Kleinman, Y. Yamada, and G.R. Martin, Science, 238, 1132 (1987). (Original) | |
| Tyr-Pro-Phe-Pro-Gly ⢠2H2O (M.W. 579.64 ⢠36.03) C30H37N5O7 ⢠2H2O [72122-63-5] V. Brantl, H. Teschemacher, A. Henshen, and F. Lottespeich, Hoppe-Seylerâs Z. Physiol. Chem., 360, 1211 (1979). (Original; Isolation) A. | |
| Tyr-Pro-Phe-Pro-Gly (M.W. 579.64) C30H37N5O7 [72122-63-5] V. Brantl, H. Teschemacher, A. Henshen, and F. Lottespeich, Hoppe-Seylerâs Z. Physiol. Chem., 360, 1211 (1979). (Original; Isolation) A. Henschen, F. Lottspeich, V. Brantl, and... | |
| Tyr-Pro-Phe-Pro-Gly- Pro-Ile ⢠4H2O (M.W. 789.92 ⢠72.06) C41H55N7O9 ⢠4H2O [72122-62-4] V. Brantl, H. Teschemacher, A. Henshen, and F. Lottespeich, Hoppe-Seylerâs Z. Physiol. Chem., 360, 1211 (1979). (Original; Isolation)... | |
| Tyr-Pro-Phe-Pro-Gly- Pro-Ile (M.W. 789.92) C41H55N7O9 [72122-62-4] V. Brantl, H. Teschemacher, A. Henshen, and F. Lottespeich, Hoppe-Seylerâs Z. Physiol. Chem., 360, 1211 (1979). (Original; Isolation) A. Henschen, F. Lottspeich, V. Brantl,... | |
| Tyrosyl-B-Type (Brain) Natriuretic Peptide-32 (Human) Tyr-Ser-Pro-Lys-Met- Val-Gln-Gly-Ser-Gly- Cys-Phe-Gly-Arg-Lys- Met-Asp-Arg-Ile-Ser- Ser-Ser-Ser-Gly-Leu- Gly-Cys-Lys-Val-Leu- Arg-Arg-His (Disulfide bond between Cys11-Cys27) (M.W. 3627.2) C152H253N51O44S4 For RadioimmunoassayA. Rosenzweig and C.E. Seidman, Annu. Rev. Biochem., 60, 229... | |
| Tyrosyl-C-Type Natriuretic Peptide-22 (Human) Tyr-Gly-Leu-Ser-Lys- Gly-Cys-Phe-Gly-Leu- Lys-Leu-Asp-Arg-Ile- Gly-Ser-Met-Ser-Gly- Leu-Gly-Cys (Disulfide bond between Cys6-Cys22) (M.W. 2360.8) C102H166N28O30S3 For Radioimmunoasay J. Brown and Z. Zuo, Am. J. Physiol., 266, R1383 (1994). (Pharmacol.)... | |
| Tyrosyl-Corticotropi n-Releasing Factor (Human, Rat) Tyr-Ser-Glu-Glu-Pro- Pro-Ile-Ser-Leu-Asp- Leu-Thr-Phe-His Leu-Leu-Arg-Glu-Val- Leu-Glu-Met-Ala-Arg- Ala-Glu-Gln-Leu-Ala- Gln-Gln-Ala-His-Ser- Asn-Arg-Lys-Leu-Met- Glu-Ile-Ile-NH2 (M.W. 4920.6) C217H353N61O65S2 [100513-58-4] For Radioimmunoassay P.C. Wynn, G. Aguilera, J. Morell, and K.J. Catt, Biochem. | |
| Vasoactive Intestinal Contractor (Mouse) Cys-Ser-Cys-Asn-Ser- Trp-Leu-Asp-Lys-Glu- Cys-Val-Tyr-Phe-Cys- His-Leu-Asp-Ile-Ile- Trp (Disulfide bonds between Cys1-Cys15 and Cys3-Cys11) (M.W. 2573.9) C116H161N27O32S4 N. Ishida, K. Tsujioka, M. Tomoi K. Saida, and Y. Mitsui, FEBS... | |
| Vasoactive Intestinal Peptide Antiserum (Rabbit) Antiserum: lyophilized from 0.001 M Phosphate Buffer (pH 7.0) Immunogen: VIP-TG (TG: Bovine Thyroglobulin) Specificity: VIP 100% Secretin (Human) <0.1% Glucagon (Human) <0.1% GRF (Human)... | |
| VKGILS-Amide M.W. 614.79 C28H54N8O7 Negative Control of PAR2 Agonist PAR-3889-PI PAR REVERSE 3889 S.K. Bohm, W. Kong, D. Bromme, S.P. Smeekens, D.C. Anderson, A. Connolly, M. Kahn, H.A. Nelken, S.R. | |
| YAPGKF-Amide (M.W. 680.81) C34H48N8O7 Protease-Activated Receptor 4 (PAR4) Negative Control Peptide for PAR-3674-PI M.D. Hollenberg, M. Saifeddine, S. Sandhu, S. Houle, and N. Vergnolle, Br. J. Pharmacol., 143, 443 (2004). | |
| YVMGHFRwDRFG (M.W. 1570.81) C74H99N21O16S Potent and Selective Melanocortin 3 (MC3) Receptor Agonist D. Marks, V.J. Hruby, G. Brookhart, and R.D. Cone, Peptides, 27, 259 (2006). P. Grieco, P.M. Balse, D. |
| << Prev | Next >> |